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ABSTRCT
CD4+ T cells playa central role in immunity. Durg virus infections, CD4+ T cells
provide the necessary help for B cells to secrete anti-viral antibody and may act 
effector cells themselves though the secretion of anti-viral cytokines such as IFN-
'Y and
TNF -a. Recent studies in the lymphocytic choriomeningitis virus (LCMV) system have
shown that CD4 + T cells are required to maintain the clearance of persistent viral
infections as well as maintain virus-specific memory CD8+ cytotoxic T lymphocytes
(CTL). Despite these important fuctions, surprisingly little information exists
concerning the longevity, magnitude, and stability of the CD4 + T cell response following a
virus infection. This thesis takes advantage of the well-studied LCMV system to address
the above issues as well as to exame the role CD4+ T cells play during heterologous
virus infections and to determine the fate of CD4+ T cells following a high-dose LCMV
infection.
The cell surface phenotype of the CD4 + T cells was first examed in C57BL/6 mice
acutely infected with LCMV F ACS analysis revealed the modulation of several
activation markers on CD4+ T cells during an acute infection with LCMV , consistent with
an activated cell phenotype. In addition, 25% of the CD4+ T cells were blast-sized by
day 7 post-infection (p.i.) even though the total number of CD4+ T cells did not increase
in the spleen during the acute infection. Additional studies were performed using CZ- , a
novel monoclonal antibody (mAb)' previously generated in our laboratory that defines a
sialic acid-dependent CD45RB-associated epitope. Examination of the expression of the
CZ- l antigen on CD4+ T cells following LCMV infection revealed that the blast-sized
CD4+ T cells at day 6 p.i. were CZ- l +. Furher cell surface phenotyping showed that
those blast cells activated at day 6 p.i. were CD45RB CD44 CD62L-. This contrasts
with the CZ- CD45RB CD44 CD62L + resting cell population prior to infection. To
determine if memory CD4 + T cells continued to express the CZ- 1 epitope long after
resolution of the LCMV infection CD4 +CZ- I + and CD4 +CZ- r- populations were
purified by cell sorting and placed into an in vitro proliferation assay with LCMV-
infected antigen-presenting cells (APC). It was found that the CD4+CZ- 1 + population
contained virtually all of the virus-specific memory. Thus , these studies indicate that the
CZ- l epitope defines a novel activation and memory marker for murine CD4+ T cells.
Examnation of virus-specific cytokine production using ELI SPOT assays showed a
significant increase in the number of IFN-
'Y-secreting cells in the spleen durg an acute
LCMV-infection. CDS+ T cells made up the majority of the IFN-
'Y- producing cells, but
analysis of the cell culture supernatants by ELISA revealed that the CD4+ T cells
produced more IFN-
'Y on a per cell basis. No significant increase in IL- levels was
detected under these experimental conditions. These data suggest that LCMV infection
induces primarily a virus-specific Th1 response that is characterized by increased IFN-
production.
Vll
No quantitative information was known about the frequency and longevity of the
LCMV -specific CD4+ T cell response. Using limiting dilution assays (LDA), I examed
the CD4+ T cell precursor (Thp) frequency in C57BL/6 mice infected with LCMV. The
virus-specific CD4+ Thp frequency increased from 1/100 000 in uninfected mice to a
peak of approximately 1/600 in FACS-purified splenic CD4+ T cell populations by 10
days p.i. with LCMV. After the peak of the response, the CD4 + Thp frequency
decreased only about 2- fold per CD4+ T cell to approximately 1/1200 and remained stable
into long-term memory. The CD4+ Thp frequency to each of the two known LCMV
major histocompatibility complex (MHC) class II-restricted peptides dropped only 2- to
fold from the peak of the acute LCMV response into long-term memory. Thus, the
CD4 + T cell frequencies remain elevated after the acute infection subsides and remain
extremely stable throughout long-term immu..rlity.
The above results show that LDA can account for 1% of the CD4+ T cells as being
virus-specific following LCMV infection. However, using newer, more sensitive assays
based on intracellular cytokine production, :;20% of the CD4+ T cells secreted IFN-
after stimulation with phorbol myristic acid and ionomycin durng the peak of the acute
CD4+ T cell response. In addition, :;10% of the CD4+ T cells secreted IFN-
'Y after
stimulation with the LCMV MHC class II-restricted CD4 peptides. Thus, these new
sensitive assays reveal a heretofore unappreciated, yet profound antigen-specific CD4+ T
cell response during LCMV infection.
Vil
Infection of mice with a senesof unrelated viruses, termed heterologous vIruses
causes the reduction of memory CDS+ T cells specific to earlier infections. In order to
examine the fate of CD4+ T cells under these conditions , I examined cytokine production
and followed the CD4+ Thp frequency following heterologous virus infections. Challenge
of LCMV immune mice with vaccinia virus (VV) resulted in a significant increase in both
the amount of IFN -
'Y protein and the frequency of IFN -'Y- producing cells in the peritoneal
cavity 3 days after infection as compared to control non-immune mice acutely infected
with VV or to LCMV-immune mice alone. Intracellular IFN-
'Y staining revealed that both
CD4+ and CD8+ T cells contributed to this increased IFN-
'Y production. LDA analysis of
the LCMV-specific CD4+ Thp frequency following multiple heterologous virus infections
or protein antigen immunizations, revealed that the CD4 + Thp frequency remains stable
even under conditions that reduce the LCMV-specific CDS+ CTLp frequency.
Additional studies using high-dose LCMV Clone 13 demonstrated that, like CD8+ T cells
there is a decline in detectable LCMV -specific CD4 + Thp durng overwhelmg virus
infections.
The data presented in this thesis help provide a better understanding of the CD4+ T
cell response durng virus infections. I make several novel observations, including the
demonstration that mAb CZ- 1 defines a novel activation and memory marker for CD4 + T
cells, that the LCMV -specific memory CD4 + Thp frequency remains extremely stable
into long-term immunity, and that heterologous virus infections do not disturb the stable
memory CD4 + T cell pool following a virus infection. I also provide data using new
sensitive assays based on intracellular cytokine production that there is a much more
profound antigen-specific CD4+ T cell response durg viral infections than has
previously been realized. Finally, I provide evidence that the virus-specific CD4+ T cells
become unresponsive following a high-dose LCMV Clone 13 infection. Thus, the data
presented in this thesis highlight some important similarties and differences between the
CD4+ and CD8+ T cell responses during acute viral infections.
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CHATER I
INODUCTION
A. Antigen recognition and activation of T cells. The immune system has evolved
several mechansms to defend the host against foreign antigens. The immune response can
be broadly divided into two arms, the humoral imune response that is characterized by
antibodies produced by B cells, and the cell-mediated immune response that 
characterized by the various actions of T cells. Both of these arms of the immune system
play vital roles in protecting the host from pathogens, including viruses (Doherty and
Kaufmann, 1994; Sher and Coffman, 1992). Anti-viral antibodies can bind to and
inactivate extracellular virions as well as mediate the destruction of infected cells through
antibody-dependent mechanisms. Both of these mechanisms allow antibodies to limit the
spread of the virus in the host. However, durg many virus infections the actions of T
cells are necessary to destroy the majority of already infected cells. Thus, T cells playa
central role in the immune response to many virus infections (Doherty et aI. , 1992;
Zinkernagel , 1996).
The majority of mature T cells express aT cell receptor (TCR), which is a membrane-
bound heterodimer composed of (X and chains (Fields and Mariuzza, 1996). T cells that
express (X/~ TCR can be divided into cells expressing either CD4 or CD8 surface antigens.
cells bearg the CD4 marker are generally considered to compnse the helper
component of the immune system, whereas T cells bearng the CD8 marker are cytotoxic
cells capable of destroying infected cells in the body.
The T cell response to a virus infection begins with the activation and expansion of
virus-specific T cell populations. Antigen-specific T cell activation is dependent on a
series of complex cell-cell interactions between T cells and antigen presenting cells (APC),
which express major histocompatibility complex (MHC) proteins (Germain, 1994). The
MHC proteins are highly polymorphic cell surace glycoproteins that bind antigenic
peptides within the cell and present them at the cell surface. CDS+ T cells recognize
peptides bound to MHC class I molecules , which are expressed by all nucleated cells in
the body (Schwarz, 1985). Most MHC class I proteins bind, in the endoplasmic
reticulum , to peptides that are derived from endogenously synthesized proteins. Crystal
structures of MHC class I molecules complexed with peptides have demonstrated that
the MHC class I peptide-binding groove is closed at both ends and that the NH - and
COOH-terminal ends of the peptide form hydrogen bonds with residues within the
pocket of the binding groove (Germain, 1994). MH C class I molecules require the
peptide for proper folding and due to these interactions , the lengt of peptides bound to
MHC class I molecules is limited to 8- 10 amino acids. In contrast CD4 + T cells
recognize peptides bound to MHC class II molecules. MHC class II proteins are
constitutively expressed on a limited number of bone marow-derived cell populations
such as macrophages, dendritic cells, and B cells. Since these are the only cells in the
body that express constitutive levels of both MHC class I and class II proteins , these cell
populations are often referred to as professional APC (Brown et aI., 1993). Newly
synthesized MHC class II molecules are complexed with an invariant chai that prevents
peptide-binding to the MHC and targets the class II molecules to late endocytic
compartments where, after disassociation with the invariant chain, these molecules can
bind antigenic peptides (Germain , 1994; Schwartz, 1985). Most of these peptides are
derived from exogenous proteins that are internalized by the APC. In contrast to MH C
class I molecules, MHC class II proteins are not dependent on peptides for proper
folding, and their 'peptide,.binding groove is open at both ends (Sadegh-Nasseri and
Germain , 1992; Stern et aI., 1994). These characteristics allow MHC class II molecules
to present peptides from 10-35 amino acids in length. Thus, T cell activation begins with
the recognition of antigenic peptides bound to MHC molecules on APC by T cells bearing
the appropriate antigen-specific TCR.
Activation of naive T cells requires two signals. Sign one is received though the
TCR after engaging an antigen-MHC complex on an APC (Schwartz, 1985). The second
costimulatory signal is provided by one or more distinct APC surface molecules
interacting with coreceptors on the T cells (Mondino and Jenkins , 1994). The TCR and
other cell surface molecules initiate T cell activation by transducing signals across the
plasma membrane of the T cell as well as increasing the avidity of the T cell-APC
interaction. These signals induce the transcription of several genes in the T cell, including
those encoding interleukin 2 (IL-2) and the IL-2 receptor, and also induce a progression
from G to the G phase of the cell cycle. The subsequent production of IL- , its
secretion, and binding to the IL-2 receptor, are thought to signal the cell to progress from
into S (Mils et al., 1993; Nakamura et aI. , 1993). Naive T cells that receive signals
through the TCRin the absence of proper co stimulatory signals are induced into a state of
unresponsiveness , termed anergy (Matzinger, 1994). This failure of T cells to proliferate
in response to cross-linkng of the TCR alone stems from their inability to secrete IL-
Thus, followig T cell activation, IL-2 acts as a strong growih factor promoting the
expansion of the activated T cell population. Following additional exposures to antigen
IL-2 secreting T cells wil differentiate into cells capable of secreting multiple cytokines
termed T helper 0 (ThO) cells (Elson et aI. , 1995; Firestein et aI. , 1989).
During a virus infection, these virus-specific T cells will undergo fuher expansion and
continued differentiation into effectors until the virus is eliminated. Once the virus is
cleared, the expanded effector T cell population goes through a contraction phase , leaving
behind a stable pool of memory T cells that provide long-term immunity (Ahmed and
Gray, 1996; Dohert et al., 1996; Welsh et aI. , 1995). The mechansms that determine
and regulate this transition from effector to memory T cells are poorly understood.
B. CD4+ T cell subsets. As mentioned above, followig initial stimulation, naive T
cells secrete primarily IL- With further stimulation, these cells differentiate into
effector cells capable of secreting a wide range of cytokines (Bradley et aI. , 1991). Upon
closer examination of the cytokines secreted by CD4-r T cell clones, it was noticed that
the clones would often secrete distinct patterns of cytokines. This important observation
led to the separation of CD4+ T cells into Thl and Th2 subsets (Mosmann et aI., 1986;
Mosmann and Coffman, 1989; Mosmann et al. , 1991). Thl cells produce IL- , interferon
gamma (IFN-
'Y), and lymphotoxin (tumor necrosis factor beta, TNF-~), whereas Th2 cells
secrete IL- , IL- , IL-6, IL- , IL- , and IL- 13 (Mosmann et al. , 1986; Mosmann and
Coffman, 1989; Mosmann and Moore, 1991; Openshaw et aI. , 1995). Several other
cytokines are not tightly restricted to either subset and are often secreted by both Th 
and Th2 cells. These include IL- , tumor necrosis factor alpha (TNF-a), and
granulocyte-macrophage colony-stimulating factor (Mosmann and Coffman, 1989). T
cells producing cytokines typical of both Th 1 and Th2 clones have also been described in
murine and human systems. These have been termed ThO cells, and may represent the
precursors of the polarized Th1 and Th2 phenotypes (Elson et aI. , 1995; firestein et aI.
1989; Miner and Croft, 1998; Sad and Mosmann , 1994). A fourth subset of CD4+ T
cells , termed Th3 , has recently been proposed for CD4+ T cells that secrete high levels 
transforming growt factor beta (TGF-
~).
These cells may play important roles in
downegulating immune responses and may represent the suppressor T cell population
the presence of which has long been suggested in the literature (Letterio and Roberts
1998; Sanders et aI. , 1988). Although the Thl and Th2 subsets were initially reported
using mouse T cell clones, this distinction has now been shown using CD4+ and CD8+ T
cells from infected or uninfected mice and in cells derived from humans (Biron, 1994;
Firestein et aI., 1989; Kagi et aI. , 1995; Launois et aI., 1995; Romagnani, 1991; Sad and
Mosmann , 1994; Sher and Coffman , 1992).
In vitro studies examg CD4+ T cell differentiation have elucidated several of the
factors required to develop polarized Th1 or Th2 cell populations. These studies have
shown that the cytokine milieu present durng the priming of naive CD4+ T cells
determines the ultimate differentiation pathway that is followed. Thus, IL- , IFN 'Y, and
TGF- induce the differentiation of Thl cells whereas IL-4 induces the development of
Th2 cells (Bradley et aI. , 1996; Hsieh et aI. , 1992; Hsieh et aI., 1993; Murphy, 1998;
Garra, 1998; O'Garra and Murphy, 1994; Seder et aI. , 1993; Seder et aI. , 1992).
Additional studies suggest that these polarized effector Th1 or Th2 cells may arise from a
common naive T cell precursor that is uncommitted to either subset, i.e. the ThO cells
mentioned earlier (Miner and Croft, 1998; Nakamura et al., 1997; Sad and Mosmann,
1994). The cytokines secreted by these polarized Thl and Th2 cells are also mutually
inhibitory for the differentiation and effector functions of the reciprocal subset. IFN-
selectively inhibits the cytokine production and proliferation of Th2 cells (O'Garra and
Murphy, 1994), whereas IL- IO inbits Th1 cytokine production and cell proliferation
(Fiorentino etal. , 1991; MosmannandMoore , 1991). In addition, recent work has shown
that IL-4 can downegulate the expression of IL-12R 2 on Th2 cells, thus makg them
insensitive to IL- 12 signals that would normally induce a Th1 cell response (Rogge et al.
1997; Szabo et aI., 1997; Szabo et aI. , 1995). In addition to the potent effects of
cytokines , other factors such as genetic background, co stimulation, and antigen dose may
also regulate the differentiation of Th1 and Th2 cells (Constant and Bottomly, 1997;
Corry et aI. , 1994; Guler et aI. , 1997; Pfeiffer et aI. , 1991; Schountz et aI., 1996). Recent
studies have suggested that higher levels of antigen and co stimulation result in Th2
differentiation (Constant et aI. , 1995; Hosken et al. , 1995). There are currently no well-
defined cell surface markers that. can separate Th1 from Th2 cells. Even though most of
these studies were initially performed using CD4+ T cells, many of these same
observations have now been made using CD8+ T cells as well (Carer and Dutton, 1996;
Erard et aI. , 1993; Noble et al. , 1995; Sad et al. , 1995).
C. Role of CD4+ T cell subsets in vivo. The functionally different subsets of CD4
and CD8+ T cells that develop upon exposure to foreign antigen have important
consequences for successful host defense. Many of the effector functions of T cells are
mediated by the cytokines they secrete (Biron, 1994; O'Garra and Murphy, 1994).
Through their production of IFN-
'Y and TNF -~, Th1 cells promote cell-mediated imune
responses. Thl-derived cytokines promote cytotoxic and inflamatory responses,
acti vate macrophages to become more bactericidal and induce delayed-type
hypersensitivity (DTH) reactions (Mosmann et aI., 1986; O'Garra and Murphy, 1994).
In addition, Thl cells can provide some B-cell help to produce antibodies, as IFN -'Y is the
major switch factor for antibodies of the IgG2a isotype in the mouse (IgG 1 in the human).
Antibodies of the IgG2a isotype promote phagocytosis by activating the classical
complement pathway and binding to Fe receptors on macrophages. Thus, Th1 responses
are often responsible for the eradication of intracellular pathogens (Biron, 1994;Sher and
Coffman , 1992). In contrast, Th2 cells, through their secretion of IL- , IL- , and IL-
provide help for B-cells to produce antibodies including the IgA, IgE, and IgG 1 isotypes
(lgG4 in humans) (Mosmann and Sad, 1996). Th2 cytokines also activate and recruit
mast cells as well as induce eosinophil proliferation and differentiation (Sher and
Coffman, 1992). Eosinophils are thought to playa direct role in causing infamation of
the airways and astha. Thus, Th2 responses are generally associated with allergic or
anti- inflammatory responses and are characterized by strong antibody responses.
Therefore , Th1 cells favor cellular immunity whereas Th2 cells favor humoral immunity.
The regulation of the type of T cell response and other effector mechanisms chosen
durng an immune response can determine host susceptibility or resistance to many
pathogens. The importance of Thl versus Th2 responses in vivo initially became
apparent in the experimental model of Leishmania major infection. In this system
resistant strains of mice, such as C57BL/6, mount a vigorous Th1-dominated response
whereas susceptible strains, such as Balb/c , generate a Th2-dominated response (Guler et
aI. , 1996; Sher and Coffman, 1992). Furthermore, it was shown that susceptible mice
could be made resistant by converting the Th2 response to a Th 1 response by treating
susceptible mice with anti-IL-4 monoclonal antibodies (mAb) (Bogen et aI. , 1993; Louis
et aI. , 1998). In addition to Leishmania major Thl and Th2 cells play an important role
in the immune response to several other pathogens. For example, Th1 responses are
associated with protective imune responses in several mouse models of infection to
intracellular bacteria, protozoa, and fungi. These include pathogens such as Trypanosama
cruzi, Candida, Bordetella pertussis and Listeria monocytogenes (Hary et aI. , 1996;
Mencacci et al. , 1998; Sher and Coffman, 1992). Th1 responses have also recently been
associated with more severe disease in several mouse experimental models of autoimmune
disease , whereas Th2 responses favor protection (Chen et aI. , 1994; Falcone and Bloom
1997; Khoury et aI. , 1992; Peterson et aI. , 1992). ' Thus , Th2 responses are not always
detrimentaL In fact, protective Th2 responses are also seen in several mouse models of
heliminth infections including Trichuris muris, Nippostrongylus brasilensis, and
Schistosoma mansoni (Chensue et aI. , 1996; Metwali et aI., 1996). In humans, subclinical
Mycobacterium leprae infections are associated with strong DTH responses to
mycobacterial antigens whereas disseminated leprosy is associated with a lack of DTH
reaction and increased production of antibodies (Yamamura et aI., 1997). In addition
recent studies have shown that humans with IL- 12 receptor deficiencies are more
susceptible to both mycobacterial and Salmonella infections (Altare et aI., 1998; de long
et aI. , 1998). Thus, the cytokines produced by T cells and other cell types can play an
important role in determining the outcome of many infectious diseases. However
, there is
only a limited amount of data concernng the effects of Thl and Th2 subsets and their
cytokines on immunity to virus infections.
D. CD4+ T cell memory. One important feature of the immune system is its ability
to "remember" previously encountered antigens and generate a more rapid imune
response which plays an essential role in protecting the host following a secondar
exposure to the antigen. In functional terms , T cell memory can be characterized by an
increased frequency of antigen-specific T cells that give a much larger, broader, and more
accelerated response to antigen as compared to that elicited durg a primary immune
response (Swain , 1994). Thus, memory involves at least two types of change in T cells
clonal expansion through cell proliferation, and the differentiation of this expanded
population into long-lived memory T cells (Dutton et aI. , 1998). One of the reasons that a
secondary immune response is stronger than a primary imune response is that memory
T cells specific for previously encountered pathogens can exist at frequencies 100-fold or
greater than naive T cells. Memory T cells also differ qualitatively from naive T cells, and
this may explain why the secondary immune response occurs more rapidly.
comparison to naive T cells, memory T cells have less stringent activation requirements
which make them capable of responding to lower doses of antigen, a wider range of APC
as well as being activated by TCR signals in the absence of co stimulation (Croft, 1994;
Croft et aI. , 1994; Croft et aI. , 1992). These attributes may, at least in part, be due to the
higher expression of several adhesion and activation molecules on memory cells as
compared to naive T cells, as discussed in more detail below.
Naive and memory T cells express a different of pattern of cell surface markers that
may be used to distinguish between the two populations. One such marker is CD45 , a
transmembrane tyrosine phosphatase found on the surface of all nucleated cells of
hematopoietic origin (Thomas, 1989). Alternative splicing of three consecutive exons
named A, B , and C , generate eight different cell surface isoforms of CD45 that vary in
molecular mass from 180-220 kDa (Johnson et aI. , 1989; Trowbridge, 1991). In addition
the extracellular domai of CD45 may be heavily glycosylated, further increasing the
heterogeneity of these proteins (Trowbridge and Thomas, 1994). CD45 is expressed on
all mature T cells, but different isoforms are expressed at vanous stages of T cell
development and differentiation (Thomas and Lefrancois, 1988). CD45 isoform
expression is used to identify CD4+ T cells at distinct stages of differentiation. For
example, human CD4+ T cells can be divided into two populations based on stainig with
mAb to CD45RO and RA (Akbar et al. , 1988; Smith et aI. , 1986). T cells recognized by
anti-CD45RA mAb express the high molecular weight isoforms of CD45 and exhbit
characteristics of naive T cells. In contrast, mAb directed against CD45RO stains T cells
expressing the lowest molecular weight isoform ofCD45 , and these cells are capable of
responding to recall antigen (Bell, 1992; Beverley, 1992; P1ebanski et aI. 1992).
Furthermore CD45RA cells have been shown to convert to CD45RO cells upon
activation in vitro (Byrne et aI. , 1988). Thus, in the human, naive T cells are CD45RA 
and CD45RO- whereas memory T cells are CD45RO+ and CD45RA-
. However, studies
have demonstrated a conversion of CD45RO+ cells to CD45RA + cells in vivo.
addition, other work has shown that memory T cells capable of responding to recall
antigens may be recovered from both CD45RA and CD45RO populations. These results
suggest that memory T cells may regain the expression of markers associated with a naive
cell phenotype.
In mice, the CD45 staining pattern for naive and memory T cells is not as clear cut due
to the lack of an antibody specific for the mure CD45RO form. Some investigators
have used the density of cell surface expression of CD45RB to distinguish naive and
memory CD4+ T cells (Gray, 1993). Naive CD4+ T cells stain CD45RB , whereas
memory CD4+ T cells stain CD45RB (Lee et aI. , 1990). However, the density of cell
surface expression of CD45RB on T cells can change with activation or with cytokine
treatment (Bunce and Bell, 1997).
Other differences in the expression of cell surface markers help distinguish naive and
memory CD4 + T cell populations. Most of these other markers are adhesion molecules
that play important roles in the traffcking of T cells throughout the body. The
proteoglycan CD44 (also known as Pgp- 1) serves as a cell adhesion receptor, and its
ligand, hyaluronate , is commonly expressed on extracellular matrices (Butcher and Picker
1996). Memory. CD4+ T cells express higher levels of CD44 than naive T cells
(Butterfield et al. , 1989). However, CD44 has limitations as a memory marker because its
level of expression varies in different strains of mice (Budd et al., 1987; Lynch and
Ceredig, 1989). The lymph node homing receptor, CD62L (also known as L-selectin and
MEL- 14 in mice) is another marker used to distinguish naive and memory T cells.
CD62L regulates T cell migration by mediating lymphocyte attachment to the high
endothelial venules of peripheral lymph nodes (Gallatin et aI. , 1983). Naive T cells are
CD62L hi and lose expression following activation (Bradley et al., 1992; Bradley et aI.
1991). However, CD62L phenotype may not be permanently stable, as some memory
T cells appear to regain CD62L expression (Razvi et aI. , 1995). CD49d and CD11a (also
known as LFA- 1) are two other, though less well studied, molecules that are upregulated
on memory T cells (Ewing et aI., 1995). Each of these intergrins are involved in T cell
binding to endothelial cells (Butcher and Picker, 1996). Thus, none of the adhesion
molecules examined to date is a reliable marker for murine memory T cells.
The problems with these markers are furher magnfied when CD8+ T cells are
considered. Many ofthese markers, especially the CD45 family, show different patterns
of expression between the CD4+ and CD8+ T cell subsets (Hou and Doherty, 1993). In
addition, CD8+ memory T cells exhibit increased expression of markers such as Ly6C
(Tough et ai., 1996) and CDllb (Mac- I) (McFarland et ai., 1992) that are not
upregulated on memory CD4 + T cells. Thus, there are clear phenotypic differences
between naive and memory T cells, but none of the current markers can differentiate
absolutely between the two subsets. In addition, another problem with all of these cell
surface molecules is that their pattern of expression on memory T cells is similar to that
on activated T cells, making them more appropriately termed activation/memory markers.
Several of the surface proteins that have altered expression patterns on memory T cells
as discussed above also contribute to the distinct recirculation pathways found between
naive and memory T cells. Memory T cells selectively traffic from blood to peripheral
tissues, while naive T cells selectively traffic from blood to lymph nodes (Bradley and
Watson, 1996). This movement of memory T cells through a broader range of tissues
may also contribute to more rapid memory responses, as these cells are capable of
responding to antigen in sites that are mostly devoid of professional APC. Thus
memory T cells actively patrol the distant sites of the body for the occurence of
infection, whereas naive T cell migration is relatively restricted to the lymphoid tissues
that are better suited to initiate a primary imune response. Despite its fundamental
importance to the long-term survival of the host, the underlying mechanisms 
immunologic memory remain poorly defined.
E. CD4+ T cell response to viruses. As discussed above, CD4+ T cells are potent
regulators of the immune system as a consequence of the cytokines that they are capable
of producing. In contrast to the experimental bacterial and parasite models mentioned
earlier, much less is known concerng the CD4-i T cell response durng virus infections.
CD4+ T cells provide the necessary help for B cells to secrete anti-viral antibody and may
act as effector cells themselves through the secretion of anti-viral cytokines such as IFN-
and TNF-a (Biron, 1994; Dohert et aI. , 1997; Zinkemagel, 1996). In several virus
models CD4+ T cells are necessar to control viral infections, as mice depleted or
genetically deficient in CD4+ T cells fail to control viruses such as adenovirus, herpes
simplex virus (HSV), and murne gamaherpesvirus-68 (MHV -68) (Christensen et aI.
1994; Doherty et al. , 1997; Doherty et aI., 1997; Manckan and Rouse, 1995; Thomson et
aI. , 1996; Von Herrath and 01dstone, 1997). In addition, loss of CD4+ T cells and their
impaired functions durng hun1an immunodeficiency virus (HIV) infection is associated
with a loss of virus-specific CD8+ T cells and an increase in viral load as well as a greater
susceptibility to other infectious agents (McMichael and Philips , 1997; Pantaleo et aI.
1997; Pere1son et aI. , 1997).
Providing B cells with the help necessary to produce anti-viral antibodies is one of the
primary roles CD4 + T cells play durng virus infections. Whereas some viruses are able
to directly cross-link B cell receptors and thus promote T-independent antibody
responses (Szomolanyi-Tsuda and Welsh, 1996; Szomolanyi-Tsuda and Welsh, 1998),
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most anti-viral antibody responses are T cell dependent and thus require CD4+ T cell help
(Bachmann and Zinkernagel, 1996). Mice genetically deficient in CD4+ T cells are more
susceptible to viruses inwhich anti-viral antibody plays an important role in resolution of
the infection such as with influenza virus, Sendai virus, and vesicular stomatitis VIruS
(VSV) (Doherty et aI., 1997; Graham and Braciale, 1997). The antibody response to
many viruses is dominated by secretion of antibodies of the IgG2a isotype, suggesting
primarily a Th1 cell response (Doherty et al. , 1997). However, the presence of Th2 cells
including the presence of antibodies of the IgG 1 isotype, has been detected durg several
viral infections, including durg the late stages of HIV infection in humans (Alonso et al.
1997; Clerici and Shearer, 1994; Cohen, 1993; Fujimura et aI. , 1997; Meyaard et at, 1994;
Mo et aI. , 1995; Romagnani and Maggi , 1994; Sarawar et aI. , 1996; Sarawar and Doherty,
1994; Wasik et aI. , 1997). These results suggest that the T cell cytokine responses durg
many virus infections may not be as polarized as the T cell responses discussed above for
the bacterial and parasitic infections. However, the importance of polarized virus-specific
cell populations has been demonstrated durng respiratory syncytial virus (RSV)
infection. In this system, mice immunized with the F glycoprotein of RSV mount a Th 
dominated response, whereas mice immunzed with the G glycoprotein of RSV mount a
Th2-dominated response (Srikiatkhachorn and Braciale, 1997). Following a challenge
with live RSV, mice previously immunized with the G protein show enhanced lung
pathology and are more susceptible to the virus as compared to mice immunized with the
F protein. Studies have demonstrated that this enhanced immunopathology is due to the
virus-specific Th2 cells induced by immunization with the glycoprotein
(Srikiatkhachornand Braciale, 1997). In addition, studies in the influenza virus system
have demonstrated that adoptive transfer of Th1 cell lines can mediate viral clearance
whereas adoptive transfer of Th2 cell lines or treatment of anals with IL-4 delay the
clearance of this virus (Graham et al., 1994; Moran et aI., 1996). Thus, the relative
balance between a Th1 versus a Th2 cell response may also play an important role in the
resolution of some virus infections.
The role of CD4 + cells in the induction of virus-specific CD8+ T cell responses
varies between experimental systems. CD8+ CTL responses to VSV , influenza virus , and
HSV are significantly diminished in mice that lack CD4+ T cells (Battegay et aI. , 1996;
Jennings et aI. , 1991; Tripp et aI. , 1995). In contrast, the CD8+ CTL response to
lymphocytic choriomenigitis virus (LCMV) and ectromelia virus seem to be less
dependent on CD4+ T cells (Ahmed et aI. , 1988; Buller et aI., 1987; Doherty, 1993;
Matloubian et aI. , 1994; Nahll and Welsh, 1993). For example, there is only a 2-fold
reduction in the CD8+ cytotoxic T lymphocyte precursor (CTLp) frequency in CD4-
deficient mice as compared to normal mice infected with LCMV (Van Herrath et aI.
1996). The reasons why some CD8+ CTL responses are more dependent on the presence
of CD4+ T cells is not clear. It has been suggested that viruses such as LCMV that induce
massive CD8+ CTL responses may obviate the need for CD4+ T cell help because the
frequency of responding CD8+ CTL may make enough cytokines such as IL-2 to support
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the expansion and differentiation of the entire population of CD8+ CTL. The number of
viral peptide-MHC complexes that an APC presents to a CD8+ CTL has also been
suggested as another factor determining the requirement for CD4+ T cell help (Lezzi et al.
1998; Viola and Lanzavecchia, 1996). CD8+ CTL that are activated in a high antigen
density environment may be less dependent on CD4 + T cell help. Thus, viruses that
replicate more efficiently in APC , such as LCMV or ectromelia virus, will engage more
TCR on the CD8+ CTL, makg them less dependent on co stimulation or cytokines
provided by CD4+ T cells.
CD4+ T cells do play an important role in sustaining CD8+ CTL responses durg
chronic viral infections (Cardin et aI. , 1996; Matloubian et al., 1994). This has been
shown most clearly in the LCMV system , in which CD8+ T cells are unable to clear a
persistent LCMV infection in the absence of CD4+ T cells (Matloubian et al. , 1994).
Additional work in the LCMV system has demonstrated that the amount of virus
necessar to clonallydelete, or "exhaust " the CD8+ CTL is significantly lower in CD4-
deficient mice as compared to CD4-competent mice (Battegay et aI. , 1994). Such a
collapse of the CD8+ T cell response has also been reported in CD4-deficient mice
infected with MHV -68 (Cardin et aI., 1996). In this disease, the lytic phase of the virus
re-emerges several months after infection ofMHC class II-deficient mice, which go on to
develop a wasting disease and eventually die (Cardin et aI., 1996). Recent work
examg HIV - infected humans has correlated decreased CD4+ T cell responses with
elevated viral loads (Rosenberg et al. , 1997). Thus , the progressive loss of virus-specific
CD8+ CTL activity that occurs durg HIV infection seems to parallel the decline in the
CD4+ T cell numbers. The underlying mechanisms by which CD4+ T cells maintain
CD8+ CTL during persistent viral infections are not well understood. The CD8+ T cells
may need cytokines , such as IL- , secreted by the CD4 + T cells in order to surive and
not become exhausted in the high antigen environment (Zajac et aI., 1998). Another
possibility is that CD4+ Tcells sustain the activation of professional APC. CD4+ T cells
promote the activation of dendritic cells through the interaction of CD40-ligand on the
CD4-r T cell and CD40 on the dendritic celL Recent work has suggested that dendritic
cells playa critical role in stimulating naive CD8+ T cells (Bennett et aI. , 1998; Ridge 
aI., 1998; Schoenberger et aI., 1998). Thus, durg persistent virus infection, CD8+ T
cells may need the CD4+ T cells to maintain the activation of the APC in order to
continue the priming of naive CD8+ CTL. Interestingly, a recent report has shown that
mice deficient in CD40-ligand fail to efficiently control LCMV , as high levels of virus re-
emerge several months after the initial infection (Thomsen et al. , 1998).
The role of CD4+ T cells in the maintenance of CD8+ T memory is less well-studied.
Recent work in the LCMV system has also suggested that CD4 + T cells may be
necessary to maintain virus-specific memory CD8+ CTLp (Von Herrath et aI. , 1996).
The mechanisms by which CD4+ T cells are required to maintain memory CD8+ T cells
may be similar to those discussed above for sustaining CD8+ T cell responses durg
chronic viral infections. However, it would seem in this case that the secretion of
cytokines such as IL-2 and IFN-'Y by the CD4+ T cells may play the more important role
by stimulating memory T cell proliferation and/or promoting the surival of memory
CDS+ T cells.
F. Acute T cell response to LCMV. Virus infections are potent stimulators of the
immune system (Ahmed and Gray, 1996; Doherty et aI. , 1996; Zinkemagel et aI. , 1996).
Most examnations of these processes in viral infections have focused on CDS+ T cells
which vigorously respond to many viral infections. Infection of mice with LCMV is a
well-characterized model system for studying the immune response durg a VIruS
inection (Zinkernagel, 1996). The kinetics of the CDS+ CTL response to LCMV
infection varies with the infecting dose of virus as well as the age of the anal (Selin and
Welsh, 1994). Durng a low-dose acute LCMV infection of adult C57BL/6 mice, the
CDS+ T cells expand as much as 5 to 20-fold, resulting in a conversion of the CD4 to
CDS ratio from 2:1 to 1:2-3 (Selin and Welsh, 1994). The majority of these CDS+ T cells
express activation markers such as CD25 , CD44 , and Mac- l (McFarland et aI., 1992;
Razvi et aI. , 1995). Many of these CDS+ T cells are blast-sized by day 6 post- infection
(p.i.), and by day 8 p.i. , 25% of the CD8+ T cells have clearly defined cytoplasmic
granules containing perforin and serine esterases (Welsh et aI. , 1990; Young et aI., 1989).
The presence of CDS+ CTL capable of lysing virus-infected targets can be easily detected
during this time. Coincident with this activation and expansIOn in the CD8+ T cell
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number is an increase in the frequency of virus-specific CTL p as detected by limiting
dilution analysis (LDA) (Assmann- Wischer et aI. , 1986; Selin et aI. , 1996). Under these
experimental conditions, virus is cleared by days 7-S p.i. and most of the activated T cells
become sensitized to activation-induced cell death and die via apoptosis between days 9-
14 p.i (Razvi and Welsh, 1993). Interestingly, even though there is a 10-fold reduction in
the total number of CDS+ T cells durng this time, the LCMV-specific CD8+ CTLp
frequency per CDS+ T cell only drops 2-fold from the peak of the response and thereafter
remains stable for the life of the mouse (Selin etaI. , 1996). This slight 2-fold reduction in
the virus-specific CDS+ CTLp frequency occurs for each of the 3 immunodominant
LCMV MHC class I-restricted peptides suggesting that, from the peak of the response
there is little selection in the specificity of memory T cells that are maintained into
memory (Selin and Welsh, 1994). These observations have been substantiated by recent
work from our laboratory showing, using complement determining region 3 length
spectratyping, that the virus-induced T cell repertoire changes little from the peak of the
response into memory (Lin and Welsh, 1998). A much different pattern emerges
following infection of adult C57BL/6 mice with a high-dose of certain strains of LCMV
(Clone 13 , Docile), which have the capacity to rapidly grow to high titers in all the
peripheral organs (Moskophidis et al. , 1993). Under these conditions, the CD8+ T cells
become activated and then clonally deleted (exhausted) under the weight of the high
antigen load, thereby preventing clearance of the virus and the establishment of CD8+ T
cell memory. Thus , these mice become persistently infected with LCMV (Moskophidis
et aI. , 1993). It is currently unclear what happens to the fate the virus-specific CD4+ T
cells under these conditions of overwhelming virus infection.
Either due to a low efficiency or because a low percentage of antigen-specific cells are
cytotoxic, LDAonly account for a small fraction (5- 10%) of the activated CD8+ T cells
during the acute LCMV infection (Lauet al., 1994; Selin et aI., 1996). Previous work
suggested that the majority of the activated cells observed durg virus infections may be
due to bystander activation mediated by cytokines such as type I interferons (i.e. IFN-a
and IFN- ) that are produced in response to the viral infection (Gray, 1996; Tough et aI.,
1996; Tough and Sprent , 1996). However, because there is little expansion in the number
of T cells not specific to the virus during infection (Zarozinski and Welsh, 1997), our
laboratory concluded that the great majority of activated cells durg LCMV infection is
virus-specific. A similar conclusion has been reached in recent studies using MHC class I
tetramers loaded with immunodominant viral peptides and using intracellular staining for
IFN-
'Y following virus-peptide stimulation (Butz and Bevan , 1998; Gallimore et aI., 1998;
Murali-Krishna et aI. , 1998). These techniques can now account for nearly 70% of the
CD8+ T cells that respond during an acute LCMV infection (Murali-Krishna et aI. , 1998).
It is currently unclear if the disparity between the frequency of virus-specific CD8+ T
cells observed using these new techniques as compared to using LDA are due to the
detection of mutually exclusive populations of CD8+ T cells.
G. T cell memory following LCMV infection. As mentioned above , previous work
from our laboratory with several viruses has demonstrated that when the apoptotic
events reduce the T cell number after viral clearance , the virus-specific CTL p frequency
per CD8+ T cell remains remarkably high in the memory state , within 12 to 50% of the
levels seen at the peak of the acute infection (Selin et aI. , 1996). In addition, this virus-
specific memory CD8+ . T cell response is extremely long-lasting, and, in the case 
memory CD8+ CTLp to LCMV, is maintained at steady state levels for the life-time of
the mouse (Asano and Ahmed, 1996; Lau et aI. , 1994; Selin et aI. , 1996). Most, but not
all, of the LCMV -specific memory CD8+ CTLp are found in cells bearg 
CD44 CD62L phenotype (Razvi et aI. , 1995). At least some of these cells also express
IL-2 receptors and are blast-sized , suggesting that a portion of the memory CD8+ T cells
continue to cycle (Razvi et aI. , 1995). Moreover, our laboratory has recently
demonstrated that enrched blast-sized CD8+ T cells over a year after the infection has
cleared can still mediate direct cytotoxic activity against sensitive targets (Selin and
Welsh, 1997). These results indicate that, long after a viral infection has cleared, the
memory CD8+ T cell pool remains highly biased with virus-specific T cells, closely
reflecting the population present at its peak durig infection but partially diluted with
naive cells (Selin and Welsh, 1994).
Memory CD8+ T cells specific for one virus can be stimulated by unrelated viruses
termed heterologous viruses. Previous studies have demonstrated that infection of
LCMV -immune mice with viruses such as Pichinde virus (PV), vaccinia virus (VV), or
murine cytomegalovirus (MCMV) result in a reactivation of LCMV 
-specific CD8+ CTL
(Selin et aI. , 1994). LDA analysis of short-term CD8+ CTL clones revealed that cross-
reactivity between the first and second virus accounts for at least a portion of these
reactivated memory T cells (Selin et aI. , 1994). More recent work from our laboratory
has suggested that the stable memory CD8+ T cell pool may be disrupted followig
heterolQgous virus infections. Work from our laboratory has demonstrated that there is a
reduction in the CD8+ CTLp frequency to earlier viruses following a heterologous virus
infection (Selin et aI. , 1996). Thus, following the resolution of an acute virus infection
the T cells from the most recent infection are selected to enter the memory T cell pool
while memory T cells from earlier infections are selected against and deleted (Selin and
Welsh, 1994). The mechanisms that mediate this reduction remain to be defmed. It is
currently unclear ifCD4+ T cells can also cross-react between heterologous viruses and 
heterologous virus infections will disrupt the virus-specific memory CD4+ T cell pooL
:,;
H. Thesis objectives. The goal of this thesis was to determine the magnitude and
longevity of a CD4+ T cell response following a virus infection. Despite the importance
of CD4 + T cell responses durg various infections discussed above, little information
exists concerng the magnitude, longevity, and stability of the CD4+ T cell response
during a virus infection. The generation of the mAb CZ- 1 and its initial characterization
(Brutkiewicz et aI. , 1993; Vargas-Cortes et aI. , 1992) led me to first question whether this
marker represented a new memory marker on CD4 + T cells. Using LCMV infection of
C57BL/6 mice, one of the most well studied mure virus models, I provided evidence
that CZ- 1 defines a novel activation and memory marker on virus- induced murine CD4+ T
cells. These studies laid the ground work to pose additional questions, and I have taken
advantage of the LCMV system to ask the following important fundamental questions:
1. Does LCMV infection elicit a cytokine response that is polarized or a mixtue of Thl
and Th2 cells?
2. What is the magnitude of the CD4+ T cell response induced by LCMV infection?
.) .
What is the size and longevity of the memory CD4+ T cell pool that is generated
following an acute virus infection?
4. Do memory CD4+ T cells play any role in contributing to heterologous T cell-
mediated immunity?
5. Do heterologous virus infections perturb the CD4+ memory T cell pool?
6. What is the fate of the virus-specific CD4+ T cells following an overwhelming virus
infection?
CHATER II
MATERIS AN METHODS
A. Mice. Six to eight-week old male C57BL/6J (H- ) and C57BL/6-CdSa mlMak mice
were obtained from The Jackson Laboratory (Bar Harbor, ME). All mice used in this
study were between 6 weeks and 2 years of age and maintained in the anmal facilities at
the University of Massachusetts Medical School, Worcester.
B. Viruses, protein antigens , and inoculations of mice. The LCMV Arstrong
strain and the AN3739 strain of PV were propagated in baby hamster kidney cells
(BHK2I), as described previously (Welsh et aI., 1976). The WR strain ofVV was grown
in L929 cells (Yang et aI. , 1989). MCMV , strain Smith, was obtained from the salivary
glands of infected Balb/c mice (Bukowski et aI. , 1983). For acute virus infections, mice
were inoculated intraperitonealy (i. ) with 5 x 10 PFU' s LCMV, 4 x PFU' s PV, 1
X 10 PFU' s VV, or 1 x PFU' s MCMV. In order to prevent CD4+ T cell activity
against cell debris or fetal calf serum (FCS) antigens present in the virus stock, the virus
preparations were either significantly diluted in phosphate buffered saline (PBS) (LCMV
and MCMV) or purified over sucrose gradients and diluted in PBS (PV and VV). Mice
inoculated with a single virus were infected between 6-S weeks of age. Immune mice used
in all memory experiments were infected with virus no less than 6 weeks previously.
Mice receiving multiple virus infections were immunzed with a sublethal dose of one
virus , rested for at least S weeks to allow the immune system to return to homeostasis
then challenged with the next virus. The highly disseminating LCMV Arstrong Clone
13 variant was kindly provided by Dr. M. A. Oldstone, Scripps Clinic and Research
Foundation, La Jolla, CA. Adult mice to be persistently infected were given
approximately 6 x 10 PFU' s of LCMV Clone 13 intravenously (i. ). Before injection
LCMV Clone 13 was concentrated through 30% (w/v) sucrose and diluted in PBS
containg 10% normal mouse seru in order to reduce the amount of FCS antigens
present in the virus stock.
For protein antigen stimulation, mice were injected i.p. with either 100 j.g of keyhole
limpet hemocyanin (KLH, Sigma, S . Louis? MO) in emulsified complete Freund'
adjuvant (CF A, Difco Laboratories, Detroit, MI) or 100 j.g ovalbumin (OVA, Sigma) in
emulsified TiterMax Gold adjuvant (TMG, Sigma).
C. Preparation of cells. Mice were sacrificed by cervical dislocation, and spleens
were removed aseptically. Splenic leukocytes were obtained by preparing single-cell
suspensions from spleens and treating them with 0. S4% NH Cl to lyse erythrocytes, as
described previously (McFarland et al., 1992). . Cell culture medium was either MEM
:f.
containg 10% FCS (Sigma), 100 U/ml of penicilin G, 100 J-g/ml of streptomycin
sulfate, and 2 mM L-glutame, or RPMI medium (Sigma) containig FCS, penicilln
streptomycin, L-glutamine (as described above), 5 x 10 5 M 2-mercaptoethanol (Sigma),
1 J-M sodium pyruvate (Gibco/BRL, Grand Island, NY), 0. 1 mM nonessential amo
acids (Gibco/BRL), and 10 mM N- hydroxyethylpiperazine- 2-ethanesulfonic acid.
D. Antibodies and reagents. The following mAb in various conjugate combinations
were used for cell surface analysis and cell sorting: anti-CD4 (clones HI29.19, and RM-
5), anti-CDS (clone 53- 7), anti-NK1.1 (clone PK136), anti-CDlla (clone 2D7), anti-
CD25 (clone 7D4), anti-CD44 (clone IM7), anti-CD45R/220 (clone RA3-6B2), anti-
CD45RB (clone l6A), anti-CD49d (clone RI- 1), anti-CD62L (clone MEL- 14), and anti-
CD69 (clone HI.2F3). All were purchased from Phargen (San Diego, CA). Tri-color
conjugated anti-CD4 (clone CT-CD4) and anti-CDS (clone CT-CDSa) were used in some
multi-parameter fluorescence-activated cell sorter (F ACS) experiments (both from Caltag,
Burlingame, CA). L3T4 (clone GK1.5) is an anti-CD4 mAb that was used in the CD4
blocking experiments (American Type Culture Collection, Rockvile, MD). The anti-
CD8 (clone 2.43) used in the elutriation experiments was kindly provided by Dr. R.
Fujinami , University of Utah, Salt Lake City, UT. The rat anti-mouse mAb CZ- 1 (lgM)
was generated in our laboratory, as described previously (Vargas-Cortes et aI. , 1992). For
the detection of primary antibodies, the followig secondary reagents were used: mouse
-I.'
anti-rat F(ab' h-specific fluorescein isothiocyanate . (FITC) from Jackson
Immunoresearch Labs (West Grove , PA), avidin FITC from Becton Dickinson (San Jose
CA), and streptavidin-Red 670 from Gibco/BRL. Recombinant human IL-2 was obtained
from Cellular Products (Buffalo, NY).
E. Plaque assays. LCMV was titrated by plaque assay on vero cell (A TCC)
monolayers. Blood from LCMV -infected mice was obtained by tail-bleeding and diluted
immediately 1: lOin complete RPMI and stored at -SOoC. The frozen aliquots were
thawed on the day of the plaque assay and used to titrate the virus on vero cells grown in
6-well plates (Costar, Cambridge, MA). Serial ten fold dilutions of 100 J.l were added to
the cells in 1 ml of MEM media and incubated for 90 mi at 37 C with repeated rockig.
AI: 1 mixture of 1 % Seakemp agarose (FMC , Rockland, ME) and EMEM (Bio Whittaker
Walkersville, MD) supplemented with antibiotics and 10% FCS was overlaid onto the
cells. The plates were incubated at 37 C and on day four stained with 2 ml of the above
overlay mixtue containing 0. 1 % neutral red (Sigma). LCMV plaques were counted on
day 5.
F. Centrifugal elutriation. Spleen leukocytes were separated on the basis of size
by a Beckman JE-6B centrifugal elutriation system (Beckman Instruments, Palo Alto
CA) as described previously (Biron and Welsh, 1982). At a constant rotor speed of 3200
;).:
RPM, cells were eluted at flow rates of 15 , 22, 28 , and 45 mVmi (Fractions 1-4).
Fraction 1 contains cell debris and some erythrocytes and was discarded. Fraction 2
consists of small lymphocytes with very little cytoplasm and a mode diameter of about
3 J.m. Fraction 3 consists of slightly larger lymphocytes with more significant
cytoplasmic area, and a mode diameter of about 7.3 J.m. Fraction 4 consists of large
lymphocytes , macrophages , and granulocytes. Cells in fraction 4 are heterogenous in size
and include virtually all ofthe activated blast-size lymphocytes.
G. Flow cytometry and cell sorting. For multicolor F ACS analysis , approximately
1 X 10 cells were stained in staining buffer (2% FCS and 0.02% NaN in PBS). Stained
cells were resuspended in PBS, fixed with 2% paraformaldehyde, washed and
resuspended in staining buffer and analyzed using a Becton ' Dickinson F ACScan flow
cytometer. Single-color controls were used in all multiparameter F ACS analyses for
electronic compensation settings on the flow cytometer and between 10 000 and 20 000
events were acquired from each preparation. Lymphocyte populations were first gated
based on forward scatter and 90 side-scatter and then analyzed using either PC-Lysis or
Cell Quest software (Becton Dickinson).
For CD4+ T cell cycle analysis, splenic leukocytes from individual anals were
stained with FITC-conjugated anti-CD4 (clone H129. 19) from Pharingen. After
washing in staining buffer, the cells were subsequently fied in ice-cold 95% ethanol and
then washed in PBS and stained with propidium iodide (Sigma). Approximately 1 x 10
cells were stained, and greater than 20,000 events were acquired from each preparation.
The data were analyzed using Cell Quest software (Becton Dickinson).
For annex in V staining, splenocytes were stained with phycoerythrin (PE)-conjugated
anti-CD4 (clone H129.l9, Pharingen) for 20 min on ice, washed several times in PBS
and then stained with anexi V-FITC (Pharngen) for 15 mi at room temperature in
anexin V staining buffer (R&D Systems, Minneapolis, MN). Stained cells were
resuspended in PBS, fIxed with 2% paraformaldehyde, washed and resuspended in
stainig buffer and analyzed using a Becton Dickinson F ACScan flow cytometer.
Approximately 1 x 10 cells were stained, and 20 000 events were acquired from each
preparation. The data were analyzed using Cell Quest software (Becton Dickinson).
F or sorting CZ- 1 + and CZ- 1- subpopulations , 5 x lOT splenocytes were stained with a
dilution ofmAb CZ- 1 for 30 min at 4 C. The cells were then incubated sequentially with-
mouse anti-rat 
'Y F(ab' )2-FITC (Jackson Immunoresearch Labs), normal rat seru , and PE-
conjugated anti-CD4 (Pharingen) with washes in between each step. The cells were
resuspended in RPMI medium and sorted on a F ACST AR Plus flow cytometer from
Becton- Dickinson.
For sorting CD4+ and/or CD8+ T cells, 1 to 2 x splenocytes from a pool of 3-
mice were stained with PE-conjugated anti-CD4 and FITC-conjugated anti-CD8
(Pharingen). They were then sorted in 2-color mode at high speed on a F ACST AR Plus
flow cytometer equipped with a turbo sort package from Becton-Dickinson. When only
CD4+ T cells were to be collected, the lymphocytes were first gated on CDS- cells to
ensure few contaminating CDS+ T cells in the sorted CD4+ T cell populations.
For sorting CD4-i T cells expressing various activation antigens, 2 x splenocytes
from a pool of 3-4 mice were stained with PE-conjugated anti-CD4 (Pharngen), Tri-
color-conjugated anti-CDS (Caltag), and a FITC-conjugated mAb (Pharingen) for the
activation marker of interest. The lymphocytes were first gated on CDS- cells to ensure
few contaminating CDS+ T cells in the sorted CD4+ T cell populations.
H. Limiting dilution assay of virus-specific precursors. LDA to detect LCMV-
specific CD4 + Th precursors (Thp) were performed based on modifications of established
protocols (Ewing et aI., 1995; Miler and Reiss, 1984; Topham et aI., 1996). CD4+ or
CDS+ T cells were sorted as described above. Sorted CD4+ and CDS+ cells were
consistently :;94% pure. Cultures were set up in 96-well U-bottom plates (Falcon
Lincoln Park, NJ) in a final volume of200 J.l in RPMI medium. Dilutions of sorted CD4+
T cells in 100 J.l were plated as replicates of 16 or 24 microcultues with 3 x 10
uninfected (mock-infected with BHK21 cell supernatant) or LCMV -infected irradiated
(2000 rads) peritoneal exudate cells (PEC) added in an additional 100 J.L To determine
the frequency of peptide-specific CD4 + Thp, PEC were pulsed with 5 J.g/ml of one of the
two known LCMV MHC class II -restricted peptides GP61-
(GLNGPDIYKGVYQFKSVEFD) or NP309-328 (SGEGWPYIACRTSIVGRA WE). For
determinations ofKLH or OVA-specific CD4+ Thp, PEC were pulsed with 100 Jlglml 
the appropriate protein antigen. The cultures were incubated at 37 C in a 95% air/5%
atmosphere. At various times after the initiation of the cultures , the plates were
centrifuged at 1000 rpm for 5 min, 50 Jll aliquots of the supernatants were transferred to
new plates , and IL-2 activity was measured using the CTLL-2 biological assay. Briefly,
the CTLL-2 cells were grown in 25-cm2 flasks in complete RPMI medium supplemented
with 1 U/ml of recombinant IL-2 (Cellular Products). The CTLL-2 cells were washed 3
times with complete RPMI , and 5 x 10 CTLL-2 cells in 50 Jll were added to 50 Jll of the
cell culture supernatants in 96-well plates and incubated for 18 h at 37 C in a 95% air/5%
atmosphere. Wells were then pulsed with 1 JlCi of tritiated thymidine (eH)TdR)
(Amersham, Arlington Heights , IL) in 50 j.l of complete RPMI for 6 h. The plates were
harvested onto glass fiber filters, and eH)TdR incorporation was assayed in a Walac
Betaplate scintillation counter (Wallac, Gaithersberg, MD). In 2 experiments IL-
activity was determined by the proliferation of the IL-4 dependent cell line, CT.4S
(kindly provided by Dr. W. Paul, National Institutes of Health, Bethesda, MD). Briefly,
50 Jll aliquots of the supernatants were incubated for 24 h with 5 x 10 CT AS cells in 50
Jll and then pulsed overnight with 1 j.Ci of (3H)TdR. Microcultures giving values in the
CTLL-2 or CTAS assay of greater than 3 standard deviations above the mean values
obtained for APC alone were scored as positive. The ffequencies were corrected for the
purity of the sorted CD4 + populations. Frequencies were calculated using X analysis
according to the method of Taswell (Taswell, 1981) on a computer program kindly
provided by Dr. Richard Miller (University of Michigan, Ann Arbor, MI). The
frequencies reported against unnfected APC are estimated, as the curves generated from
the responder dilution series often yielded linear regression lines that never crossed the
37% negative well threshold. Thus, these frequencies may reflect slight overestimates of
the background response to unnfected APC. However, the response against uninfected
APC was always significantly lower than that against virus-infected APC in all of the
LCMV -infected mice.
I. Proliferation assays. Cultures were set up in quadruplicate in 96-well U-bottom
plates (Falcon) in a final volume of200 III in complete RPMI medium. Sorted cells were
plated at 7 x cells/well in 100 ilL PEC were obtained from mice injected with
thioglycollate i.p. 4 days previously and with LCMV 3 days previously. Irradiated
(2000 rad) PEC (1.5 x 105) were added to each well in a volume of 50 ilL Medium, anti-
CD4 (L3T4), or IL-2 were added to the appropriate wells to a fmal volume of 200 Ill.
The plates were centrfuged briefly to pellet the cells, then incubated at 37 C in a 95%
air/5% C02 atmosphere for 4 days. After 4 days the cultures were pulsed with 1 IlCi of
eH)TdR (Amersham) for 18 h. The cells were harvested onto glass fiber fiters, and
eH)TdR incorporation was determined by liquid scintillation counting.
J. Intracellular cytokine staining. Intracellular cytokine staining was performed
based on modifications of recently published protocols (Murali-Krishna et aI., 1998;
Openshaw et aI., 1995). To assess intracellular cytokine expression in cells activated
nonspecific ally, 2 x 10 spleen cells were cultued at 37 C for 4 hr in 50 ng/ml of phorbol
myristic acid (PMA, Sigma) and 500 ng/ml of ionomycin (Sigma), with either 10 J.g/ml of
brefeldin A or 2 J.M monensin (both from Sigma) added for the fmal 2 hrs to enable
intracellular proteins to accumulate. F or antigen-specific expression of cytokines
splenocytes were cultured at 37 C for 5 hr at a concentration of 2 x cells/tube in a
volume of 1 ml of complete RPMI medium supplemented with 10 U/ml of recombinant
human IL-2 (Pharngen) and 10 J.g/ml of brefeldin A or 2 J.M monensin (both from
Sigma) in the presence (5 J.g/ml) or absence of one of the two LCMV MHC class II-
restricted peptides. After 5 hr culture , the cells were harvested, washed once in staining
buffer, blocked with purified anti-FcyRII/III mAb (clone 2.4G2, Phargen) for 10 
on ice , and stained for surface markers for 30 mi on ice. The cells were then washed in
staining buffer and fixed with 2% formaldehyde in PBS for 20 min at room temperature.
Following two washes with permeabilization buffer (staining buffer containig 0.
saponm, Sigma), the cells were resuspended in 100 III of permeabilization buffer and
incubated for 10 min at room temperature , followed by an additional 30 min incubation
after the addition of a directly conjugated anti-cytokine mAb or appropriate isotype
matched control mAb (Pharingen). The followig mAb were used in various conjugate
combinations: anti-IL-2 (clone JES6-5H4), anti-IL- (clone 11B11), anti-IL- (clone
TRFK5), anti-IL- lO (clone JES5- 16E3), anti-IFN-'Y (clone XMG 1.2), and anti- TNF-a
(clone MP6-XT22). Approximately 2 x 10 cells were stained, and between 30 000 and
000 events were acquired from each sample. Lymphocyte populations were first
gated based on forward scatter and 90 side-scatter and then analyzed using Cell Quest
software (Becton Dickinson).
K. Cytokine ELISA. Unsorted splenic leukocytes or F ACS-separated T cells were
resuspended at a final density of 1 x 10 cells per ml in complete RPMI supplemented as
above. Responders (100 Ill) were added to 3 x 10 LCMV-infected irradiated (2000 rads)
stimulator PEC in complete RPMI (200 III per well total volume) and incubated at 37
Supernatants were harvested at 24, 48 , 72, and 96hr and stored at -SOoC prior to being
assayed for cytokines by enzyme-linked immunosorbent assay (ELISA). Dynatech
Immulon 4 plates (Dynatech, Chantil , V A) were coated by incubation overnight at 4
with anti-cytokine mAb diluted in PBS (50 III per well). The plates were then washed
with PBS- 05% Tween 20 after each of the following steps. Plates were blocked with
PBS- 10% FCS (200 !Jl per well) for 2 h at room temperature. Samples were added at 100
!Jl per well , and a standard cure was constructed for each plate by using eight 2- fold
serial dilutions of recombinant cytokine, and the plates were agai incubated overnight 
C prior to the addition ofa biotinylated anti-cytokine mAb at 100 !Jl per well. After a
1 hr incubation at room temperature, 100 !Jl of avidin-peroxidase (1/400 dilution in PBS-
10% FCS; obtained from Sigm) per well were added, and the plates were incubated at
room temperature for 30 min prior to detection with 100 !Jl of the peroxidase substrate
tetramethyl-benzidine dihydrochloride (Sigma) dissolved in 0.05 M phosphate-
citrate buffer, pH 5.0. The reaction was stopped with 25 !Jl of 2 N H S04' Plates were
read at 450 nm using a THERMOMAX plate reader and analyzed using SoftMax 2.3 (both
from Molecular Devices Corporation, Menlo Park, CA). The following pairs of mAb
were used: anti-IL- , JES6-1AI2 and biotinylated JES6-5H4; anti-IL- , 11B11 and
biotinylated BVD6-24G2; anti-IL- , TRFK5 and biotinylated TRFK4; anti-IL- , JES5-
2A5 and biotinylated SXC- 1; anti-IFN-'Y, R4- 6A2 and biotinylated XMG1.2 anti-TNF-
, G28l-2626 and biotinylated MP6-XT3 (all from Pharngen). The appropriate
recombinant murine cytokines used as starJdards were also obtained from Pharngen.
Limits of detection for IL- , IL- , IL- , IL- , IFN-'Y, and TNF-a ELISA were 31 pg/ml
125 pg/ml, 60 pglml, 156 pg/ml, 0.3 nglml, 0.3 nglml, respectively. IL-4 and IFN-
protein levels were , in some cases measured using very sensitive single-plate ELISA kits
purchased from Endogen (Cambridge, MA). These kits had a limit of detection of 15
pg/ml.
L. Cytokine ELISPOT assays. Enzyme- linked immunospot assays (ELI SPOT) for
cytokine-secreting cells were performed based on slight modifications of established
protocols (Fujihashi et aI., 1993; Sarawar and Doherty, 1994). Briefly, 96-well
nitrocellulose-based microtiter plates (Milititer HA; Millipore Corporation, Bedford
MA) were coated overnight at 4 C with 50 l per well of an anti-cytokine mAb diluted in
PBS. After the plates were washed with PBS, all wells were blocked with 200 l of
RPMI containing 10% FCS for 2 hat 37 C. After washing with PBS , the lymphocyte
populations (either splenic leukocytes or F ACS-separated T cell populations) were then
added to the wells (1 x 10) to 1.3 x 10 or from 1 x 10) to 7.8 x 10 cells per well for
:c.
responders with 3 x 10 LCMV- infected irradifited (2000 rads) PEC as stimulators) in
RPMI- 10% FCS (200 l per well total volume) and incubated for 20 h at 37 C. After the
wells were washed in PBS- Tween, a biotlnylated anti-cytokine mAb was added, diluted
in PBS containing 10% FCS (1 00 l per well), and incubated overnight at 4 C. Plates
were washed in PBS- Tween, and 1 00 l of an anti-biotin mAb conjugated with peroxidase
(1/250 dilution in PBS- 10% FCS; Jackson Immunoresearch Labs) per well was added
followed by another overnight incubation at 4 C. Spots representing individual cytokine-
secreting cells were visualized by developing with the substrate 3-amino-9-ethylcarbazole
(Sigma) and counted using an Olympus SZ-STS Stereozoom microscope (Lake Success
NY). All assays were performed in triplicate. Mean numbers of cytokine-secreting cells
were calculated from the triplicate assays. The following pairs of mAb were used in the
ELI SPOT assays: anti-IL- , BVD4- 1D11 and biotinylated BVD6-24G2; anti-IFN-
'Y, R4-
6A2 and biotinylated XMG 1.2. The mAb were used at a concentration of 2 Ilg/ml, with
the exception of R4-6A2 , which was used at 10 Ilg/ml. All of the mAb were obtained
from Pharingen.
M. Statistical analysis. CD4+ Thp frequencies were calculated using X analysis
according to the method of Taswell (Taswell, 1981) on a computer program kindly
provided by Dr. Richard Miller (University of Michigan, An Arbor, MI). All other
data, where appropriate , were analyzed by Student's test for each individual experiment
using Microsoft's Excel software (Microsoft Corporation, Redmond, W A). Statistical
significance was established at a value of 05.
CHAPTER III
VISUALIZATION OF THE CD4+ T CELL RESPONSE
FOLLOWING LCMV INECTION
CD4+ T cells playa central role in the immune system. They can provide help for B
cells to produce antibodies , can provide help for CD8+ T cell responses, can activate
macrophages to become more bactericidal, and can act as effector cells themselves (Biron
1994; Doherty et aI., 1997; Zinkernagel , 1996). Most of the in vivo studies examg
CD4+ T cells have been performed using well-defined protein antigens that elicit strong
CD4+ T cell responses (Swain et aI., 1996). Much less work has been performed
examining the CD4+ T cell response during viral infection. LCMV infection of mice is one
of the most well studied experimental viral systems, yet surprisingly little information
exists concerning the magnitude of CD4 + T cell response during this model virus infection.
As mentioned in the introduction, activated T cells modulate the expression of several cell
surface molecules. In this chapter, I examined the cell surface phenotype of CD4+ T cells
during an acute LCMV infection into memory. I will show that a larger proportion of the
CD4+ T cells express activation markers during the acute LCMV infection as compared to
naive mice. In addition, I wil provide evidence that CZ- , a novel mAb produced in our
laboratory (Brutkewicz et al. , 1993; Vargas-Cortes et aI. , 1992), represents a new
activation and memory marker for mouse CD4+ T cells.
Besides cell surface phenotype CD4 + T cells may also be characterized by the
cytokines they produce (Mosmann et aI., 1986; Mosmann and Coffman, 1989). Little
quantitative information is knOW'l about the frequencies and types of cytokine-secreting
CD4+ T cells which develop after experimental viral infections. The production of IFN-
may be used to detect Th1 cells whereas the production of IL-4 may be used to detect
Th2 cells (Mosmann and Coffman, 1989). Two recent reports have detected both IFN- 'Y-
and IL-4-secreting cells following LCMV infection, suggesting that a mixtue of both Th 
and Th2 cells are indu.ced (Suet aI.
, '
998; Whitme et aI. , 1998). In this chapter I will
show, using ELISPOT assays to examine cytokine production at the single cell level, that
LCMV infection induces primarily a Th1 response characterized by an increased
frequency of IFN-
'Y- producing CD4+ and CD8+ T cells. In addition, I will provide
evidence that at least a portion of the Th2 responses that have been recently reported
(Su et aI. , 1998; Whitmire et al., 1998) may be due to FCS or cellular antigens present in
the virus stocks and not induced by the virus.
A. T cell distribution and activation phenotype of CD4+ T cells during the acute
LCMV infection and on into memory. Figure III- l shows the percentage of CD4+ and
CD8+ T cells in the spleen of C57BL/6 mice acutely infected with LCMV. Also shown
CD4
. .-- -
CD8
.: r 17.
12.
Days Post-Infection
Figure III- I. Phenotype of splenic cell populations during an acute LCMV infection of
C57BL/6 mice. Cell numbers, expressed as cell counts per spleen (.), and cell
phenotypes , expressed as percentages of total splenic leukocytes , were determined by
F ACS analysis, as described in the Materials and Methods. Means:! standard deviations
for time points from 2 separate experiments with 4 individual mice per experiment are
shown (n=8 per group). . 
in Figure III- 1 is the 2-fold increase in the total leukocyte number in the spleen that
occurs during the acute LCMV infection. The increase in the percentage of CD8+ T cells
combined with the increase in the total number of cells results in a massive 5- to 20-fold
expansion in the total number of CD8+ T cells in the spleen durng LCMV infection
(McFarland et aI. , 1992). In contrast, there is only a modest increase in the total number
of CD4+ T cells in the spleen, as the percentage of CD4+ T cells has decreased at the peak
in the leukocyte number (Fig. III - 1). Although the total CD4 + T cell number remains
relatively stable, further analyses revealed evidence of CD4 + T cell activation as shown
by blastogenesis and activation antigen expression. The mean percentage of blast-sized
CD4+ T cells from 4 individual mice per group were as follows: day 0: 8; day 3: 9; day 5:
16; day 7: 25; day 9: 21; day 11: 19; day 15: 11. Analysis of DNA content by propidium
iodide staining revealed an increase in the percentage of CD4+ T cells in the cell cycle.
The mean percentages of CD4+ T cells in G2+M or S phase from 6 individual mice per
group were as follows: day 0: 2::1; day 7: 7::2 , day 9: 6::2 , day 11: 5::1; 7 mo: 2::1; 
mo: 2::1; 19 mo: 2::1. Figure III-2 shows the distribution of CD4+ T cells following an
acute infection with LCMV with regard to the antigens CD44 (Pgp-l), a marker whose
cell surface expression increases on activatedT cells (Butterfield et aI. , 1989), and CD62L
(MEL- 14), a molecule whose cell surface expression decreases on activated T cells
(Bradley et al. , 1993). Table III- I shows that there is an increase in the mean fluorescence
intensity (MFI) of CD44 on gated CD4+ T cells, and as can be seen in Figure III- , this
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increase in the MFI is mainly due to an increase in the relative proportion of CD4+ T cells
expressing a high level of CD44 rather than all of the CD4 + T cells stainig more highly
with CD44. Likewise , Table III-I shows that there is a decrease in the MFI of CD62L on
gated CD4+ T cells , and as can be seen in Figure III- , this decrease in the MFI seems to
be due to an increase in the relative proportion of CD4 + T cells expressing a low level 
CD62L. A similar pattern emerged when the cell surface expressions of CD25 (IL-
receptor) and CD69 (very early activation antigen) were examed on CD4+ T cells
following an acute LCMV infection (Fig. in-3). However, the highest proportion of
CD4+ T cells expressing high amounts of these markers was at day 5 p.i. (p~0.05), in
contrast to CD62L and CD44 discussed above. Figure III -4 shows a more detailed time
course of the cell surface expression ofCD62L , CD44, and CD69 on gated CD4+ T cells.
Many of the CD4+ T cells stained CD62L CD44 11 days pj. , characteristic of an
activated r cell phenotype (McHeyzer-Williams et aI. , 1996; Swain and Bradley, 1992).
The peak in cell surface expression of the activation marker CD44 (day 9 MFI: 259; day
11 MFI: 252) at days 9- 11 pj. correlated with the lowest cell surface expression of
CD62L (day 9 MFI: 34; day 11 MFI: 35), a molecule whose cell surface expression
decreases on activated T cells (Bradley et al. , 1993). In contrast to CD62L and CD44
CD4 + T cell surface expression of the very early activation antigen CD69 peaked much
earlier at 3 days pj. (MF!: 41) and declined thereafter. More detailed analysis of CD69
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Figure 1II-4. Expression of CD44 , CD62L , and CD69 on CD4+ T cells durg LCMV
infection. Spleen cells from mice either unnfected (day 0) or infected with LCMV for 3
, 7 , 9, 11 , or 15 days. Splenocytes were stained with anti-CD4 and either anti-CD44
anti-CD62L , or anti-CD69 mAb. A CD4 gate was applied, and the histograms represent
the cell surface expression of CD44, CD62L , or CD69 on the gated CD4 + T cells. Data
are representative of 2 separate experiments with 4 individual mice per experiment (n=8
per group).
CD44 CD62L CD69
Day (lJ
(.:
0 10 0 10 0 10
Day ((4 (UJ0 10 0 10 0 10
(c; :C4 (I;M';" Day 5
:.'; ;.
0'; 0 10 0 10 0 10
Day? (r; (r;0 10 0 10 0 10
Day 9 
. 100 10 0 10
(G;Day (J;0 10 0 10 0 10
Day 15 (GM0 10 0 10 0 10
expression on CD4+ T cells early after LCMV infection revealed that expression of this
marker peaked at days 2-3 p.i. (data not shown).
In addition, I examed the cell surface expression of several other activation markers
and found increases in the MFI of CZ- 1 (a sialated form of CD45RB), CD25 , and CD69
as well as of the adhesion molecules CD49d (VLA-4) and LF A- I (CD11a) on gated CD4+
T cells after LCMV infection (Table III-I). CD45RB cell surface expression has been
shown to increase on effector CD4+ T cells (Bradley et al. , 1993). In agreement with this
I observed an increase in the cell surace expression of CD45RB on CD4+ T cells at day
10 pj. with LCMV. Interestingly, while CD45RB expression increases on activated cells
and then decreases on memory CD4 + T cells, the antigen CZ- , a sialic acid-dependent
CD45RB-associated epitope, is bright on activated cells and remains high on memory
CD4+ T cells. This is reflected in the higher expression of CZ- 1 vs. CD45RB on memory
CD4+ T cell populations (day 60 p.i. , Table III-I). Thus, LCMV infection induces on
CD4+ T cells an activated phenotype that peaks by days 9- 11 p.i.
B. Characterization of CZ- l as a novel CD4+ T cell activation marker. The
above experiments revealed the modulation of several activation markers on CD4+ T cells
f.(
during an acute infection with LCMV. The level of cell surface CD45RB expression has
been used to distinguish between naive and memory CD4+ T cells (Bradley et al., 1993;
Vitetta et aI. , 1991). CD4+ T cells stain heterogenously with anti-CD45RB mAb (Ernst et
aI. , 1990). Because mAb CZ- 1 defines a sialic acid-dependent CD45RB-associated
epitope (Brutkiewicz et al. , 1993), I compared the cell surface expression of the CZ-
antigen with that of CD45RB on splenocytes following an acute LCMV infection. As
expected, the staining pattern of CD4+ T cells was heterogeneous with respect to
CD45RB expression. Figure 1II-5 shows that mAb CZ- 1 stained the CD4+ T cells from
uninfected mice at a lower intensity than did the anti-CD45RB mAb, with MFI of 115
and 259 , respectively. In contrast mAbCZ- 1 stained the CD4- cells at a higher intensity
than did the anti-CD45RB mAb (MFl of 1019 and 375 , respectively). CD4+ T cells
stained more brightly for the CZ- 1 antigen at day 6 p.i. (MFl of 206), as compared to
uninfected mice (MFI of 115). In the immune mice (day 42 p.i.), mAb CZ- 1 stained the
CD4 + T cells with a slightly lower intensity (MFI of 191) overall , but some CD4 + T cells
stained brightly for the CZ- I epitope.
Since CZ- 1 and CD45RB showed slightly different staining patterns, I determined the
amount of coexpression of these two molecules on CD4-gated splenocytes before and
during an acute infection with LCMV. Uninfected and day 6 p.i. splenocytes were
stained with anti-CD4 , anti-CD45RB , and CZ- 1 (Fig. 1II-6). In the uninfected mice, both
CZ- 1 and anti-CD45RB stained CD4-gated splenocytes heterogeneously, with most cells
being CZ- and CD45RB . However, at day 6 p.i. , a subpopulation of cells stained
CD45RB and CZ- 1 hi Thus, durng an acute infection with LCMV, there is a
subpopulation of CD4+ T cells that stain CD45RB CZ-
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Figure 1II-6. Coexpression ofCZ- 1 and CD45RB on splenocytes durg an acute LCMV
infection. Spleen cells from mice either unected (day 0) or LCMV-inected (day 6)
were staned with CD4
, CD45RB , and CZ- 1 mAb. A CD4 gate was applied and the dot
plots show CD45RB versus CZ-
CZ-
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To further analyze the phenotype of the activated CD4+ T cells durg an acute
infection with LCMV , I stained splenocytes with anti-CD4 and mAb specific for various
cell surface markers and examed their density of expression in relation to cell size (as
determined by forward light scatter). Figure III-7 (upper panel) shows that the blast-
sized CD4+ T cells at day 6 pj. with LCMV were CZ- . In contrast, the majority of
the blast-sized cells were CD45RB (Fig. II-7lower panel). Figure III-S shows that the
blast-sized CD4+ T cells durng the acute infection were CD44 and CD62L-. Three-
color FACS analysis was performed (CD4 and CZ- 1 Ys. CD44 or CD62L) to further
compare the cell surface expression of the CZ- l antigen with the CD44 and CD62L
molecules. The population of cells with the highest CD44 expression at day 6 p.i. were
also CZ- 1 hi (Fig. III -9 upper panel). In addition, Figure III -9 (lower panel) shows that
those cells with low CD62L expression include mostly CZ- I hi cells. Thus, the
phenotype of the blast-sized cells durg an acute infection with LCMV is CZ-
CD45RB IOCD44 CD62L -
C. CZ-l also serves as a memory marker for virus-induced CD4+ T cells.
Because some activation molecules continue to be expressed on memory cells, I
questioned whether LCMV-specific memory CD4+ T cells expressed elevated levels 
CZ- l. Figure III - 10 shows the two-color F ACS analysis of CZ- 1 antigen expression on
CD4+ T cells in an LCMV-immune spleen six weeks p.i. The bimodal staining pattern
,,'
Day 0 Day 6
. .. . " .. " .:-" .". - '
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Figure III- i. Surfa(.e phenotype of blast-sized cells during an LCMV infection.
Splenocytes from mice either unfected (day 0) or during an acute (day 6) infection withLCMV were stained for CD4 and either CZ- l or CD45RB. A CD4 gate was applied. andthe dot plors show either CZ- l or CD45RB versus cell size. as measured by forward light
scatter. 
Day 0
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Figure III-S. Expression ofCD44 and CD62L on blast-sized CD4+ T cells durg an acuteLCMV inection. Splenocytes from mice either unected (day 0) or inected (day 6)
with LCMV were staed for CD4 and either CD44 or CD62L. A CD4 gate was applied
and the dot plots show either CD44 or CD62L versus cell size, as meaured by forward
light scatter.
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Figure 1II-9. Comparson ofCD44 and CD62L expression with the CZ- 1 antigen. Spleen
cells from mice either unected (day 0) or LCMV-infected (day 6) were stined with
CD4 , CZ- , and either CD44 or CD62L mAb. A CD4 gate was applied and the dot plots
show either CD44 or CD62L versus .C2-
Pre-Sort
R1 
~~~~~~ ' .. ,: . 
. 0
- . ... - "- '
1y; :?:;rT
1 00 1 01 1 02 10"
Post-Sort: CD4+CZ- I +2: Post-Sort: CD4+CZ-99 
('% ('%
100 101 102 103 1 () 100 101 102 103 10"
CZ-
Figu Ill-IO. Expression of CZ- 1 on splenocytes from an LCMV -imune an.
Splenocytes were sted as described in the Materials and Methods and sorted into two
populations based on CD4 and CZ- 1 expression. The Rl gate representing the CD4+CZ-population and the R2 gate representing the CD4+CZ- l+ population ar shown.
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was similar to that found in Figure III-5. I sorted splenocytes from LCMV-immune mice
into CD4+CZ- 1 + and CD4-iCZ- 1- populations (Fig. III- I 0) and determined their ability to
proliferate in response to LCMV-infected PEC in vitro (Fig. III- II). In eight independent
experiments, I found that all of the virus-specific memory was in the CD4 +CZ- I-i
comparment. Furthermore , treatment of unsorted splenocytes from an LCMV -immune
mouse with mAb CZ- 1 and complement abolished this proliferative response to virus-
infected PEC (data not shown).
Because mAb CZ- 1 also stains CD8+ T cells (Vargas-Cortes et aI., 1992), which
represented a very small contaminant (-C:1% , see Fig. III- 10) in the sorted populations , I
wanted to ensure that it was the CD4+ and not the CD8+ T cells that were responding in
the proliferation assays. As shown in Figure III- , treatment with anti-CD4 (Chance et
aI. , 1994) blocked all of virus-specific proliferation from the CD4+CZ- 1+ population.
Furthermore , the purity of the expanded CD4+CZ- I + culture was verified by stainig
cells pooled from several wells of the proliferation assay with anti-CD4 and anti-CDS
mAb. The cultures stained :;92% for CD4+ cells , with CDS+ cells accounting for ~l % 
the population (Fig. III - 12).
The lack of any memory in the CD4 +CZ- l- population could have been the result of
an increased requirement for T cell growth factors such as IL- , as these cells could have
been in a lower activation state than the CD4+CZ- I+ cells. However, the CD4+CZ-
population did not show any significant proliferation with the addition of exogenous IL-
CD4 CZ- l +
CD4 CZ- l +
with Anti-CD4
CD4 CZ-
CD4 CZ-
with IL-
. LCMV PEC
Uninfected PEC
5000 10000 15000 20000
cpm
Figure III- II. LCMV-specific memory CD4+ T cells express the CZ- 1 antigen.
The results from one of several experiments are shown in which splenocytes were
FACS-purified into CD4+CZ- 1- and CD4+CZ- + and then assayed for (3H)TdR
incorporation in response to stimulation with LCMV - infected PEe. Some wells
were incubated with anti-CD4 mAb or various concentrations of IL-2. Only the
highest IL-2 concentration used, 13.5 U/ml, is shown. There was no proliferative
response from the CD4+CZ- 1- population over the range of IL-2 concentrations
tested (0. 13.5 U/ml). Error bars represent the standard deviations of quadruplicate
cultures.
J _
; : ..: .
po . 
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1%'
100
 .
101 102
CD8
103 104
Figure III- 12. Predomiantly CD4+ T cells grow out in the proliferation cultues. A pool
from 4 wells of the expanded CD4+CZ- l+ cultue was staned with CD4 and CDS mAb.
The dot plots show CD4 versus CD8. Numbers in the quadrants represent the
percentage of cells that fall with that quadrt.
in the presence of virus-infected APC (Fig. III- ll). Previous work from our laboratory
has shown that whereas CZ- 1- T cells do not respond to IL-2 in the absence of antigen
they do proliferate in response to concanavalin A or anti-CD3. In addition, our
laboratory has shown that the CZ- 1 antigen is expressed on CD4 + T cells after activation
' i with anti-CD3 (Brutkiewicz et al. , 1993; Vargas-Cortes et aI. , 1992).
Some investigators define memory CD4 + T cells as small resting cells and distinguish
them from activated cycling cells that may persist for a time after antigen exposure (Croft
et aI. , 1994). To ensure that such chronically activated CD4+CZ- I+ T cells were not
responsible for all of the virus-specific proliferation measured in the memory cell
proliferation assays, I examed the size of the CD4+CZ- 1+ T cells in LCMV-immune
mIce. Figure 111-13 shows that there was not a significant increase in blast-sized
CD4 +CZ- 1 + T cells in LCMV -immune mice as compared to uninfected control anals
(see Fig. III-7 upper panel). The blast-size CD4+ T cells in the LCMV- immune mice
were few in number and considerably less than the frequency of blast-sized CD8+ T cells,
reported previously by our laboratory (Razvi et al., 1995). To determine whether the
small CD4 CZ- + memory T cells could proliferate when stimulated in vitro with
LCMV -infected PEC, I utilized an elutriator centrfuge to separate splenic leukocytes
based on cell size. The cells were then depleted of CD8+ T cells using anti-CD8 mAb and
complement and stimulated against LCMV -infected PEC in the presence of 1 U/ml IL-
Proliferation was seen in cells from Fraction 4 , which contains nearly all of the blast-sized
Day 42
. . ' ". . ' -.' . .
;ti;,
. ."  '' ... ..,. ':  ., .::: : .
200 400 6 800 1000
Forward Scatter 
Figu II- l3. Sma CD4+ T cells in LCMV-imune mice express the CZ- 1 antigen.
Splenocytes from LCMV-imune (day 42) mice were staied for CD4 and CZ-l. ACD4 gate was applied, and the dot plots show CZ- I versus cell size, as measured by
forward light scatter.
lymphocytes , as well as contaminating small cells. However, significant proliferation was
also observed in cells from Fractions 2 and 3 , which contain very little contamination
from larger blast-sized cells (F2: 15 545:t2 767 cpm; F3: 35 785:t30 012 cpm; F4:
677:t2 l28 cpm) (Biron and Welsh, 1982). The total cell numbers per fraction were
higher in Fractions 2 and 3 than they were in Fraction 4 (F2=3. 1 x 10 cells , F3=4.7 x 10
cells, F4=2.3 x cells), indicating that most of the memory cells were small
lymphocytes. In a second experiment, mAb to CZ- I and complement was used to treat
elutriated Fraction 2 cells, and this caused a 71 % reduction in their proliferative response
709:t414 cpm vs. 771:t475 cpm). Finally, fraction 2 cells were sorted by flow
cytometry into small CD4+CZ- I+ and small CD4+CZ- r- populations and placed into a
proliferation assay at 7 x 10 cells per welL Virtually all of the proliferation in response
to LCMV -infected PEC was in the CZ- 1 + population (CD4+CZ- 1 +: 2 690:t3 350 cpm;
CD4+CZ- : 33:t17 cpm). These experiments indicate that even the very small
lymphocytes contain LCMV -specific memory T cells and that the CZ- I + subpopulation
contains virtually all of that memory.
D. Cytokine secretion during the acute LCMV infection. The above experiments
show that CD4+ T cells expressing an activated cell surface phenotype are induced
following an acute LCMV infection. Since one of the primar effector functions of CD4+
T cells is the secretion of various cytokines, I utilized the ELI SPOT assay to assess IFN-
'Y and IL-4 production at the single-cell level in C57BL/6 mice acutely infected with
LCMV. Durng the course of my early studies using the ELI SPOT assay, it became
apparent that a portion of the cytokine response being measured was due to a memory T
cell response to FCS or cellular antigens present in our virus stocks. Thus, when 
infected mice with a LCMV stock that had been grown in BHK21 cells in medium
containing 10% FCS , a significant FCS-specific CD4+ T cell response would be generated
in addition to the virus-specific T cell response. These FCS antigen-specific CD4+ T cells
would produce both IFN-
'Yand IL- 4 when placed in the ELI SPOT assay. Table 1II-
demonstrates these findings by showing that once the virus stock is diluted in PBS , there
is a significant reduction in the frequency of cytokine-producing cells. This suggests that
most of the cytokine-producing cells previously detected were specific to FCS antigens
that would be constantly present in these in vitro assays. The addition of LCMV-
infected PEC to the assay resulted in a significant increase in the number of virus-specific
IFN-
'Y- producing cells, with only a slight increase in the number of IL- producing cells.
Even though the addition of the LCMV-infected PEC as APC does increase the number of
IL- producing cells, the proportional increase is not nearly as high as the increase that is
observed for IFN-
'Y, and it is less than the number detected following infection with an
undiluted virus. This observation, is important to note due to recent studies that have
reported, I believe erroneously, significantly elevated frequencies of IL- producing cells
following LCMV- infection (Su et aI. , 1998; Whtme et aI. , 1998). Because of these
Table III-2. Frequency of IFN-y-and IL-A-Secreting Cells on Day 7 Post-
Infection with LCMV
Spleen Leukocytes
In vivo
pnmmg
INF Cells IL-4+ Cells
per 1 x 10 per 1 x 10
155:! 122 86 :! 26LCMV Day 7
Undiluted
LCMV Day 7
DiL 1: 100 in PBS
11 :!6 4:!2
LCMV Day 7 )-1600 52:! 19 
Dil. 1 :100 in PBS
Plus LCMV APC
BHK Sup. Day 7 O:!O 4:!3
DiL 1 :100 in PBS
BHK Sup. Day 7
Dil. 1:100 inPBS
Plus LCMV APC
8:!6 7:!9
ELISPOT assays were performed as described in the Materials and Methods on spleen
cells from LCMV -infected mice. Means:! standard deviations for 4 individual mice are
shown.
;1)
c. 
.... :.
c \
.
findings, all of the experiments presented hereafter were performed with viruses either
highly diluted in PBS or purified over sucrose gradients.
Figure III-14 shows the frequency of cytokine-producing cells in the spleen of
C57BL/6 mice infected with LCMV that has been diluted in PBS before injection.
U ninfected mice (day 0) had no detectable IFN 'Y- or IL-4-secreting cells (hereafter
referred to as IFN- + and IL- + cells) in the spleen. Following an infection with LCMV
the frequency of IFN- + cells per spleen leukocyte started to increase by day 5 p.i. and
reached its peak by day 9 p.i. On a per spleen basis , the peak in the total number of IFN-
+ cells was even more pronounced at days 7- 11 p.i. , because the number of cells in the
spleen had nearly doubled (Fig. III-I). By day 15 p.i. the frequency of IFN- + cells had
started to decline. The decline in the frequency of IFN- + cells after day 7-11 p.i.
coincides with the clearance of the virus and the decline ofthe CD8+ CTL response (Selin
and Welsh , 1994). In contrast to IFN-'Y, few IL- + cells could be detected in the spleen.
I performed several additional experiments to determne if any significant virus-
specific IL-4 production could be detected following LCMV infection. Cytokine
production was first analyzed for protein production in culture supernatants from cells
that had been restimulated in vitro with virus-infected irradiated APC. In a single
experiment with four individual mice, splenocytes from LCMV-infected mice produced a
mean of 4 762 pg/ml ofIFN-'Y at day 7 p.i. and 23 540 pg/ml ofIFN-'Y at day 15 p.i. , with
Day 0 
Day 3 
Day 5
Day 7 
Day 9 
Day 11
Day 15
Day 7 BHK
Day 15 BHK
'l:
. IFN-
o IL-
100 400 500200 300
Number of Cytokine-Secreting
Cells Per 105 Splenic Leukocytes
Figure 1II- 14. Frequency of cytokine-producing cells in LCMV- infected C57BL/6
mice. ELI SPOT assays were performed for IFN-'Yand IL- 4 on freshly isolated
splenocytes taken 3 to 15 days after i.p. infection with LCMV or 7 and 15 days after
p. injection of a BHK21 supernatant controL The day 0 time point represents
uninfected mice. Means:: standard deviations for time points from two separate
experiments with two individual mice per experiment are shown (n=4 per group).
no IL-4 detected at either time point. In another experiment, conditioned media was
prepared from splenocytes at day 9 p.i. followed by assay of the supernatant for
cytokine production by ELISA. In a single experiment using 2 individual mice, no IFN-
or IL-4 could be detected in the absence of antigen stimulation. However, with the
addition of 1 Ilg/ml of one of two recently described LCMV-encoded MHC class II-
restricted (I-A b) CD4 peptides (Oxenius et aI. , 1995), production of high levels of IFN-
and very low levels of IL-4 protein became detectable (day 9 GP61-S0 peptide
stimulated: 1 292 pg/ml IFN-
'Y; 33 pg/ml IL-4). No IFN-'Yor IL-4 could be detected using
the other LCMV MHC class II-restricted CD4 peptide , NP309-32S. These experiments
show that very little, if any, virus-specific IL-4 production can be detected following
LCMV infection, even after stimulation with either of the two known LCMV MHC class
II-restricted peptides. Thus , these results suggest that LCMV infection induces primarily
a Th1 response.
E. CD4+ T cells produce more IFN-
'Y than CD8+ T cells. CD4+ and CDS+ T cells
from the spleens of mice that had been acutely infected with LCMV were purified by cell
sorting in order to determine if virus-specific CD4+ T cells contributed to the secretion 
IFN-yin the ELISPOT assays described above. Table III- , which presents the results
from 2 to 3 separate experiments per time point, shows that CD8+ T cells made up the
majority of IFN-'Y-secreting cells during the acute LCMV infection. However, there were
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detectable frequencies of LCMV -specific CD4 + T cells secreting IFN -y. The ELISPOT
assay detects secreted cytokine molecules in the immediate vicinity of the cell from which
they are derived, with each spot representing a footprint of the original cytokine-secreting
cell (Czerkinsky et al. , 1983). I noticed in these assays that, while there were on average
II-fold more CD8+ than CD4+ T cells secreting IFN-'Y, the CD4+ "spots" in the assays
were consistently larger. This suggested that the CD4+ T cells may be makg more IFN-
'Y on a per cell basis than the CD8+ T cells. Previous work with in vitro systems has
shown that CD4+ T cells can secrete higher levels of cytokines than similarly stimulated
CD8+ T cells (Carter and Dutton, 1996). To exame if this were the case durg LCMV
infection, I F ACS-purified CD4+ and CD8+ T cells at various times p.i., restimulated
them in vitro with virus , and performed ELISA assays on the culture supernatants. Table
III-3 shows that CD4+ T cells secreted as much IFN-'Y protein into the cell culture
supernatant as CD8+ T cells , even though there were II-fold more CD8+ T cells secreting
IFN-'Y than CD4+ T cells, as detected using ELI SPOT assays. This indicates that the
CD4+ T cells make more IFN-'Y on a per cell basis than do the CD8+ T cells. No IL- , IL-
, or IL- 10 was detected in any of these cultures, further showing that very little virus-
specific Th2 cytokines are produced during an acute LCMV infection.
When splenocytes from LCMV-immune mice (day 180 p.i.) were used in the
ELI SPOT assay, the frequency of unsorted and sorted CD8+ T cells secreting IFN-'Y in
the 20 h assay was greatly reduced compared to cells isolated durg the acute LCMV
infection. Using this assay, I was-unable to detect any CD4+ T cells secreting IFN-'Y 
from
the memory mice. This reduced frequency likely reflects a decrease in the activation
status of these cells as compared to the highly activated T cells 
durng the acute infection.
Thus , the ELISPOT assay performed here using LCMV -infected PEC as APC probably
does not provide a strong enough stimulus to induce memory CD4 
+ T cells to secrete
IFN-y. I wil introduce other strategies later in this thesis that 
are capable of detecting
IFN-
'Y production by memory CD4+ T cells following a stronger stimulus with peptides
in the presence of IL- , an observation that would also be consistent with the activation
status of the memory cells discussed here.
F. Brief summary of Chapter ID. I have shown in this chapter that a large
proportion of the CD4+ T cells express activation markers during the acute LCMV
infection as compared to naive mice. In addition, I provide data showing that 25% 
of the
CD4+ T cells are blast-sized by day 7 p.i. and that there is an increased number of CD4+
T cells that have entered the cell cycle. I also provide evidence that CZ-
, a novel mAb
produced in our laboratory (Vargas-Cortes et aI., 1992) (Brutkiewicz et aI., 1993),
represents a new activation and memory marker for mouse 
CD4+ T cells. Taken together
these results suggest that a high percentage of the 
CD4+ T cells become activated
following LCMV infection. In this chapter I have also provided evidence that LCMV
::,
infection induces primarily a Th 1 cytokine profile as determined by ELISA and ELISPOT
assays. Moreover, I provide data that suggest that recent reports demonstrating IL-
production following LCMV infection (Su et al., 1998; Whtmie et aI., 1998) may be
inaccurate and due to false positives caused by FCS antigens present in the inoculum.
, .:!'
CHATER IV
EXAATION OF TH LCMV-SPECIFIC CD4+ T CELL
FRQUENCY FROM ACUTE INCTION INTO MEMORY
The previous chapter demonstrated that CD4+ T cells become activated durg 
acute LCMV infection as judged by cell size, increased DNA content, expression of
various activation markers , and secretion of cytokines. Although some of these assays
indicated that as many as 25-50% of the CD4+ T cells in the spleen were activated , ~1 %
of the CD4+ T cells scored as virus-specific cells in the ELI SPOT assays measuring IFN-
production. LDA have often been used in order to quantitate the frequency of virus-
specific T cells. In the case of CD8+ CTL, these assays rely on the ability of CD8+ T
cells to lyse virus-infected target cells in very sensitive Cr-release assays. However
CD4+ T cells during LCMV - infection are not normally cytotoxic (Muller et aI., 1992;
Oxenius et aI. , 1998). Recent work in the Sendai and influenza virus systems has led to
the establishment of a CD4 LDA method that is based on IL-2 production by the virus-
specific CD4+ T cells (Ewing et aI. , 1995; Topham et aI. , 1996; Tripp et al. , 1997). This
method, in contrast to the phenotypic studies presented in Chapter III, allows for a
measurement of the magnitude of the virus-specific CD4+ T cell response. Therefore, I
adapted this method to measure LCMV -specific CD4+ Thp and present in this chapter a
quantitation of the virus-specific CD4+ T cell response. In this chapter, I will show that
the LCMV -specific memory CD4+ Thp frequency remains extremely stable into long-
term immunity. In addition, I will provide data using newer, more sensitive assays based
on intracellular cytokine production, that show that LCMV induces an even more
profound CD4+ T cell response than has been previously realized.
A. Quantitation of the CD4+ Thp frequency during the acute LCMV infection
into memory. Figure IV- I shows a typical regression line obtained from C57BL/6 mice
during the acute infection with LCMV (day 7 pj.) and into memory (day 60 p.i.) using
the IL- based LDA. Kinetic studies revealed that peak frequencies of CD4+ Thp durg
the acute LCMV infection and into memory were found after at least 48 hrs following the
initiation ofthe culture (Fig. IV - 1). The LDA results shown here suggest that memory T
cells require at least 48 hrs of stimulation to score in these assays, providing an
explanation as to why I saw a decline in the frequency of IFN-'Y-secreting cells that could
be detected using the ELISPOT assay in Chapter III.
Analysis of CD4+ Thp frequencies durg the acute LCMV- infection and on into
memory showed that the CD4+ Thp frequencies remain quite stable for at least 1 year p.i.
(Table IV-I). The LCMV-specific CD4+ Thp frequency rose from 1/100 000 in a naive
anal (day 0) to approximately 1/600 by day 10 p.i. with LCMV. This peak in the
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CD4+ Thp frequency by day 10 p.i. corresponds with that of the activation markers
CD44 and CD62L discussed in Chapter III. Interestingly, the LCMV-specific CD4+ Thp
frequency per CD4+ T cell only dropped 2-fold from the peak of the acute response
(days 9- 11 p.i. ) into long-term memory. This relatively small reduction in the CD4+ Thp
frequency mirrors the 2-fold drop in frequency that our laboratory has previously
reported for the CD8+ T cell response durg LCMV-infection (Selin et aI. , 1996). In
fact, on a per spleen basis , the decline in the total number of virus-specific memory CD4+
T cells is even less than the decline in the total number of virus-specific memory CD8+ 
cells, because the total number of CD4+ T cells in the spleen remains the same between
the peak of the acute infection and memory, whereas the total number of CD8+ T cells
decreases significantly (see Fig. III- I).
The CD4+ Thp frequencies obtained against both uninfected and LCMV -infected APC
(Table IV -1 and Table IV -2) are presented because there is consistently a low level
response against uninfected APC. Several additional controls were performed to ensure
that I was measuring LCMV -specific CD4+ Thp producing IL-2 in these assays. F ACS-
purified CD4+ T cells from a pool of 3 mice injected with a BHK21 cell supernatant
yielded low frequencies to either uninfected (1/20 807) and LCMV -infected APC
(1/22 439). Even though I used F ACS-purified CD4+ T cells in these LDA, I could not
rule out that a very small contamination (~1 %) by CD8+ T cells might be present in the
cultures and release IL-2 in response to the virus-infected APC. Using this IL- based
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LDA method, F ACS-purified CD8+ T cells at day 10 p.i. yielded frequencies of 1/2 650
and 1/2 388 in 2 independent experiments. Thus, CD8+ T cells are capable of makg
enough IL-2 to be detected in this assay. However, as shown in Table IV- , addition of
anti-CD4 mAb in myLDA using sorted CD4+ T cells , blocked all of the virus-specific IL-
2 production retug the CD4+ Thp frequency to a level comparable to that obtained
against uninfected APC. Finally, because there was the possibility that the CTLL-2 cells
used to monitor IL-2 production in these LDA could also be detecting IL- , I added anti-
IL-4 mAb to the assays. Table IV-2 shows that there was no effect (within the 95%
confdence limits) in 3 of the 4 experiments when anti-IL-4 mAb was added to the LDA
cultures. In one experiment, using LCMV- immune anmals, the presence of the anti-IL-
mAb only slightly (within the 95% confidence limits) reduced the resulting precursor
frequency. In 2 additional experiments , I used the very IL-4-sensitive CT AS cell line in
the LDA. No IL-4 could be detected using this indicator cell line at day 15 or 240 p.i. in
the LDA. The ELI SPOT and ELISA data presented in Chapter III , along with the anti-
IL-4 blockig experiments and use of the CTAS cells discussed here, suggest that the
LCMV -specific CD4+ T cells are primarily of a Th1 phenotype.
B. Quantitation of the peptide-specific CD4+ Thp frequency from the peak of
the acute infection into long-term memory. Table IV-3 shows the peptide-specific
CD4+ Thp frequencies for the two known LCMV encoded MHC class II-restricted
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peptides during the peak of the acute CD4+ T cell response and into long-term memory.
The stability of the virus-specific CD4+ Thp frequencies up to 18 months p.i. following
stimulation with LCMV - infected PEC shown here extends on the data presented in Table
IV- l regarding the stability ofCD4+ Thp frequencies into long-term memory. The CD4+
Thp frequency to each of the two LCMV MHC class II-restricted peptides dropped only
2- to 7-fold from the peak of the CD4+ T cell response into memory (Table IV-3). It is
unclear why the peptide-specific CD4 + Thp frequency yields such a varable drop-off
from the peak of the response into memory. Using the peptides as the stimulus may
allow me to detect lower affinity virus-specific CD4 + T cells than I would be able to
detect using whole virus. It is clear that a higher frequency of CD4 + T cells score as
virus-specific in the LDA using the two peptides as compared to using whole virus.
However, the peptide-specific CD4+ Thp frequencies shown here do not decline between
days 450 and 540 p.i., ageeing with the results discussed above using whole virus
showing that the LCMV -specific CD4+ Thp frequency remains stable into long-term
immunity.
C. Phenotype of LCMV-specific CD4+ Thp. The above experiments demonstrate
that, like the LCMV-specific CD8+ CTLp frequency, the LCMV-specific CD4+ Thp
frequency is extremely stable for essentially the life of the mouse. Previous work from
our laboratory has shown that the LCMV -specific memory CD8+ CTLp express
predominantly a CD44 , CD62L , CD11b phenotype (Razvi et al., 1995). However
some memory CD8+ CTLp may be found in the T cells expressing the reciprocal levels 
these markers. In addition, some of the CD44 CD62L hiCD 11 b LCMV -specific memory
CD8+ CTLp were blast-sized cells expressing IL-2 receptors (Razvi et aI. , 1995). This
suggests that at least a portion of the memory T cells are cycling. In order to analyze the
LCMV-specific memory CD4+ Thp phenotype CD4+ T cells obtained from LCMV-
immune mice were sorted for CD4 + cells expressing one of a panel of
activation/memory markers (Table IV-4). The virus-specific memory CD4+ Thp
expressed predominantly a CD44hiCD45RB10CD49dhiCD62LIOCZ- 1hi phenotype.
The
least discriminating antigen in these experiments seemed to be CD45RB, often used as a
marker for memory CD4+ T cells (Gray, 1993). A fairly high frequency of LCMV-
specific memory CD4+ Thp were found in both the CD62L hi and CD62L subsets.
LCMV -virus-specific memory CD8+ CTLp have been shown to regai expression of
CD62L over time (Razvi et al., 1995), and it seems that LCMV -specific memory CD4 
Thp also regai expression of this marker. This is important as CD62L regulates T cell
migration by mediating lymphocyte attachment to the high endothelial venules of
peripheral lymph nodes (Gallatin et aI., 1983). The two best markers at identifying
LCMV -specific CD4 + Thp were CD49d and CZ- 1. Expression of CD49d on a high
frequency of Sendai virus-specific memory CD4+ Thp has recently been reported 
(Ewing
et aI. , 1995). The results obtained here with CZ- 1 expand on my earlier characterization
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of this novel marker by confrmg that it is indeed preferentially expressed on the
LCMV -specific memory CD4 + Thp.
D. Intracellular staining of cytokine-producing CD4+ T cells. As mentioned in
the introduction, two new techniques have been developed to measure antigen-specific T
cell populations. Recent studies using MHC class I tetramers loaded with
immunodominant viral peptides and using intracellular staining for IFN -
'Y following virus-
peptide stimulation have revealed that a significantly higher percentage of CD8+ T cells
can be scored as virus-specific than has previously been detected using LDA (Butz and
Bevan, 1998; Flynn et aI., 1998; Lalvan et aI. , 1997; Murali-Krishna et aI., 1998).
Although the total CD4+ T cell number remains relatively stable durng the acute LCMV
infection (see Fig. III- I), there is an increase in the percentage of blast-sized CD4+ T cells
of CD4+ T cells with increased DNA content, and of CD4+ T cells expressing various
activation and adhesion molecules, as shown in Chapter III (Varga and Welsh, 1998).
Using ELISPOT assays (in the absence of added IL-2) to assess IFN-
'Y production at the
single-cell level, I have shown that the frequency of sorted CD4+ T cells that produced
IFN-'Y when stimulated with LCMV- infected PEC (see Table 1II-3), was similar to the
CD4+ Thp frequency in LDA measuring IL- producing cells shown in Tables IV- 1 and
IV-3. Thus , ~1 % of the CD4+ T cells can be identified by LDA or ELISPOT analysis as
LCMV -specific.
IFN-
Day 0 
IL-
Day 5
Day?
Day 9 
Day 
Day 15
Percentage of Cytokine-
Positive CD4+ T Cells
Figure IV -2. Intracellular IFN-'Y and IL-4 expression of virus- induced CD4+ T
cells following stimulation with PMA and ionomycin. Splenocytes from the
indicated days p.i. were stimulated with PMA and ionomycin for 2 hr before the
addition of brefeldin A for an additional 2 hr as described in the Materials and
Methods. The cells were gated on CD4+ cells, and the values shown represent the
percentage of CD4+ cells that expressed a given cytokine. Means:t standard
deviations for time points from 2 separate experiments with 2 individual mice per
experiment are shown (n=4 per group).
Figure IV-2 shows that a much higher frequency (:;20%) of CD4+ T cells from mice
acutely infected with LCMV make IFN-'Y when nonspecifically stimulated with PMA
and ionomycin. There was no significant increase in the percentage of IL- producing
CD4 + T cells durng the acute LCMV infection, in agreement with my earlier results
presented in Chapter III using ELISA and ELI SPOT assays. Thus, there is a much larger
percentage ofCD4+ T cells that are expressing an activated cell phenotype, that are blast-
sized and have entered the cell cycle, and that produce IFN-'Y followig polyc1onal
stimulation, than can be accounted for by using either the LDA or ELI SPOT assay (Figs.
III- , III-3, III- , Tables III- , and IV- I).
E. Intracellular staining of peptide-specific IFN- 'Y- producing CD4+ T cells. The
above experiments show that at least 20-25% of the CD4+ T cells in the acute LCMV
infection produce IFN-'Y when nonspecifically stimulated with PMA and ionomycin.
This assay detects cells that have been previously activated in vivo as the short 4 hr
stimulation with PMA and ionomycin is not long enough to activate a naive T cell or a
resting memory T ceU to produce IFN-'Y, as LCMV -immune mice do not exhbit increased
frequencies oflFN-
'Y- producing CD4+ T cells above naive control mice (data not shown).
Moreover, this assay relies on polyc1onal stimulation of the activated T cells and
therefore does not address the specificity of the responding cells. As mentioned earlier
one ofthe new techniques to measure antigen-specific T cells is by using the intracellular
IFN-
'Yassay followig peptide stimulation (Murali-Krishna et aI. , 1998). I adapted this
, method to measure LCMV peptide-specific CD4 + T cells by using the two known
LCMV MHC class II-restricted CD4 peptides. This assay is performed by stimulating
the T cells in vitro for 5 hr in the presence of peptide , IL- , and brefeldin A (to allow the
cytokines to accumulate intracellularly). The peptide-specific intracellular IFN-'Y assay,
displayed in Figure IV - , shows that )- 1 0% of the CD4+ T cells at day 9 p.i. were specific
for either of the two LCMV MHC class II-restricted peptides. CD4+ T cells produced
no IFN-'Y in the absence of peptide, and peptide-stimulated CD4+ T cells did not
demonstrate any significant intracellular staining above background with an isotype
control mAb. Figure IV -4 shows that virtually all of the GP61-80-specific CD4 + T cells
that stained positive for IFN-'Y were also CD44 , consistent with an activated cell
phenotype (Bradley et aI., 1993). Figure IV-5 shows a time course in which the IFN- 'Y-
producing cells peak at day 9 p.i. , but are stil detectable into long-term memory.
I performed several experiments using mAb specific to Th2 cytokines such as IL-
IL- , and IL- 10 and failed to detect an increase, above the levels obtained with the
appropriate isotype-matched control mAb, in the intracellular expression of any of these
cytokines following peptide stimulation (data not shown). To further make sure that no
significant virus-specific IL-4 was being produced following LCMV infection, I examed
the expression of intracellular IFN-'Y and IL-4 following LCMV infection of C57BL/6
mice genetically deficient in CD8+ T cells. Figure IV -6 shows that there is a signficant
No Peptide No Peptide
:.:: $ :.
~0.
GP61- GP61-
. R1
NP309-328 NP309-328
1.3%
Isotype IFN -
Control
CD4
Figure IV - 3. Intracellular IFN -'Y expression of LCMV peptide-specific CD4+ T
cells. Splenocytes from LCMV -infected (day 9) C57BL/6 mice were stimulated
with or without one of the two LCMV MHC class II-restricted peptides in the
presence of IL-2 and brefeldin A for 5 hr as described in the Materials and
Methods. The numbers shown indicate the percentage of CD4+ T cells that
stained positive for intracellular IFN- represented by the RI gate. Data are
representative of four experiments.
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Figure IV -5. Intracellular IFN-'Y expression of LCMV peptide-specifi
CD4+ T
cells during an acute LCMV infection into memory. Splenocytes from the indicated
days p. i. were stimulated with one of the two LCMV MHC class II-restricted
peptides in the presence of IL-2 and brefeldin A for 5 hr, as described in the
Materials and Methods. 
Background staining with the appropriate isotype-matched
control mAb was subtracted from each individuaL Means:: standard deviations for
time points from 4 separate experiments with 2 individual mice per experiment are
shown (n=8 per group).
CD4
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14%
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Figure IV-6. Intracellular IFN-'Y and IL-4 expression ofLCMV peptide-specific
CD4+ T cells from CD8 knock-out mice. Splenocytes from LCMV -infected
(day 9) C57BL/6-CD8KO mice were stimulated with one of the two LCMV
MHC class II-restricted peptides in the presence of IL-2 and brefeldin A for 5
hr as described in the Materials and Methods. The numbers shown indicate the
percentage of CD4+ T cells that stained positive for intracellular IFN-'Yor IL-4 as
represented by the Rl gate. Data are representative of2 experiments.
frequency of IFN -'Y- prcducing cells at day 9 p. i. with no increase in the frequency of IL-
producing cells. Taken together, these results are in general agreement with the 
LDA
and ELISPOT assays presented earlier showing an increase in the frequency of virus-
specific cells secreting Thl cytokines with no increase in the frequency of virus-specific
cells secreting Th2 cytokines. Thus , the main difference between the LDA or ELISPOT
results and the intracellular cytokine stains is that the latter assay scores a much 
higher
frequency of CD4+ T cells as being virus-specific.
The time course presented In Figure IV -5 using the intracellular IFN-'Y assay looks
similar in kinetics to that described earlier using the ELI SPOT assay (see Fig. III-
14). In
contrast to using LCMV -infected PEC as APC in the ELI SPOT assay, the intracellular
IFN-'Yassay uses peptide in the presence of IL-
2 to activate the T cells, and this likely
explains why the intracellular IFN-'Y assay detects a much higher frequency 
of virus-
specific CD4+ T cells as compared to the ELISPOT assay. This explanation is 
supported
by recent studies showing that the intracellular cytokine and ELISPOT assays yield
similar results when peptides and IL-2 are used as the T cell stimulus in the 
ELISPOT
assay (Murali-Krishna et aI., 1998). The same reasoning may explain the 
disparity
between the frequency of virus-specific CD4+ T cells detected using the LDA as
compared to the intracellular IFN-'Y assay. I fail to detect IL-2-secreting cells in the
intracellular cytokine assays discussed above when brefeldin A is 
used to allow the
cytokines to accumulate intracellularly. A recent report in the LCMV system has also
failed to detect them using similar assays following anti-CD3 stimulation (Su et aI.
1998). Monensin is another compound that may be used in the intracellular cytokine
assays to disrupt the Golgi and allowcytokines to accumulate. Monensin has 
been
reported to enhance the detection of Th2 cytokines such as IL-4 and IL-
10 as compared
to brefeldin A. However, I failed to detect an increase , above the levels obtained with the
appropriate isotype-matched control mAb, in the intracellular expression of 
Th2
cytokines such as IL- , IL-5, or IL- 10 during an acute LCMV infection following 
peptide
stimulation in the presence of monensin (data not shown).
Interestingly, the use of
monensin did allow for the detection of IL- producing cells in the intracellular cytokine
assay that were not previously observed when using brefeldin A. Table IV -
5 shows that
approximately 2% of the CD4+ T cells produce IL-2 when stimulated with either of the
two LCMV MHC class II-restricted peptides. Treatment with monensin does result in 
lower frequency of cells that secrete IFN-'Y (approximately 5% vs. 10% with brefeldin A).
The frequency of CD4+ T cells capable of makg TNF-a was similar to that of IFN-
(both approximately 5%) following stimulation with the LCMV MHC class II-restricted
peptides in the presence of IL-2 and monensin. This assay allows a comparison of the
frequency of virus-specific IL-2-secreting CD4+ T cells obtained with 
the LDA. The
intracellular stain using monensin is able to detect a higher frequency of 
virus-specific IL-
producing cells as compared to the LDA discussed above. This discrepancy may be
due to the addition of exogenous IL-2 in the intracellular stain which may, in combination
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with using the MHC class II-restricted peptides, allow for the detection of lower affinity
virus-specific CD4+ T cells that are not detectable using the LDA. I t is difficult to
directly test this as the LDA is measurg IL-2production by the virus-specific CD4+ T
cells using an IL-2-sensitive indicator cell line and thus prevents the addition of exogenous
IL-2 in these assays. The intracellular stain avoids this problem as human recombinant
IL-2 is used to stimul te the virus specific T cells whereas the IL- producing cells are
detected using a mAb specific for murine IL-
Using the intracellular IFN-'Y assay, the percentage of CD4+ T cells that are LCMV
peptide-specific drops 5- to 7-fold from the peak of the response into long-
term
immunity. This agrees with the results I obtained in the LDA using these two peptides
but contrasts with the consistent 2-fold drop I observe in the LDA using whole virus.
This difference may be due to the detection of lower affinity T cells following peptide
stimulation as compared to using whole virus. However, like the results obtained using
the IL- based LDA, the intracellular IFN-'Y assay revealed that the LCMV peptide-
specific CD4+ T cell frequency remains stable into long-term immunity. The 
intracellular
IFN-'Y stain following stimulation with either of the two known MHC 
class II-restricted
peptides shown here scores :;10% of the CD4 + T cells as LCMV -specific. 
In contrast
Figure IV -2 demonstrated that 20-25% of the CD4+ T cells could make IFN- 'Y 
following
polyclonal stimulation. The total number of virus-specific CD4+ T cells may be higher
than I show here, since only two CD4 peptides were used. It is likely that the 
CD4+ T
102
cell response to LCMV includes other MHC class II-restricted epitopes which have 
yet
to be identified. Thus , these new sensitive assays reveal a previously 
unappreciated
profound antigen-specific CD4+ T cell response during viral infections.
F. Brief summary to Chapter IV. In this Chapter I make two novel observations.
First, I provide data showing that the LCMV-specific memory CD4+ Thp 
frequency
remains extremely stable into long-term immunity. Second, I provide evidence using
newer, more sensitive assays based on intracellular cytokine production
, that LCMV
induces an even more profound CD4+ T cell response than has been previously 
realized.
It is possible that this second observation may be an unappreciated feature of viruses in
general, as LCMV was a virus not previously thought to be a strong inducer of CD4+ T
cells.
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CHATER V
STABILITY OF THE LCMV-SPECIFIC CD4+ T CELL FREQUENCY
FOLLOWING HETEROLOGOUS VIUS INFECTIONS I
Recent work from our laboratory has shown that serologically unelated VIruses
(referred to as heterologous viruses) can elicit cross-reactive CD8+ CTL responses that
paricipate in the early stages of the immune response when mice immune to one virus are
challenged with another virus (Selin et aI. , 1994; Selin and Welsh, 1994). Mice imune
to LCMV synthesize approximately 10-fold less PV or VV upon challenge when
compared to naive mice, and this protection can be adoptively transferred into naive mice
by T cells obtained from LCMV- immune mice (Selin et aI. , 1998; Welsh et al., 1996).
Previous studies have shown that antigen-stimulated memory T cells can secrete much
higher quantities of cytokines than recently stimulated naive T cells undergoing a primary
immune response (Bradley et aI., 1993). Therefore, in order to further define the factors
leading to this increased immunity to heterologous viruses, I utilized ELISA assays and
flow cytometric analyses of intracellular IFN-'Y to exame cytokine production at the
single-cell level following infection of immune mice with heterologous viruses. I will
I Some of the work performed in this chapter was done in collaboration with Dr. L.K. Selin (Selin et ai
1998).
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show that there is an increase in the frequency of IFN -'Y-secreting cells and IFN - 'Y protein
in the peritoneal cavity of LCMV -immune mice challenged with VV as compared to
control-immune mice infected with vv.
More recent results from our laboratory have shown that heterologous virus infections
may also disrupt the long-term homeostasis of the CD8+ T cell memory pool by reducing
the frequency of CD8+ CTLp to earlier viruses (Selin et aI. , 1996). The data presented in
Chapter IV demonstrated that the virus-specific CD4+ Thp frequency is extremely stable
into long-term immunity following a single infection with LCMV. In this Chapter, I
questioned whether heterologous virus infections would perturb the stable LCMV-
specific CD4+ Thp memory pooL I will show that the CD4+ Thp frequency is resistant
to reduction by heterologous virus infections, even under conditions that reduce the
LCMV-specific CD8+ CTLp frequency.
cell distribution and activation phenotype of CD4+ T cells following
different virus infections (LCMV PV, , MCMV). Figure V- I shows the percentage
of CD4+ and CD8+ T cells in the spleen of C57BL/6 mice acutely infected with either
LCMV , VV , PV , or MCMV. Also shown is the increase in the total leukocyte number in
the spleen that occurs during each of these virus infections. As shown in Chapter III (see
Fig. III -1), LCMV infection results in a 2- fold increase in the total leukocyte number in
the spleen and a conversion of the CD4 to CD8 ratio from 2:1 to 1 :2-3. Each of the other
105
LCMV
CD4
CD8
0. 
7.4
7.3
Days Post- Infection Days Post-Infection
MCMV
..r 
on 
0. 
Days Post-Infection Days Post-Infection
Figure V- I. CD4/CD8 ratio during acute LCMV , VV , PV , or MCMV infection. Cell
numbers, expressed as cell counts per spleen (.), and cell phenotypes for the cells
recovered from the spleens of mice infected with either LCMV , VV , PV , or MCMV. The
cell phenotypes , expressed as percentages of total splenic leukocytes , were determined by
FACS analysis , as described in the Materials and Methods. Means:t standard deviations
for time points from 3 separate experiments with 2 individual mice per experiment are
shown (n=6 per group).
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viruses induce an increase in the total leukocyte number in the spleen as well as a
conversion of the CD4 to CD8 ratio. However, none of the other viruses induce these
changes to the extent LCMV infection does. I presented data in Chapter 
III showing that
there is an increase in the proportion of CD4 + T cells expressing activation markers such
as CD44 (see Fig. III-2 and Table III- I), consistent with an activated phenotype. Here 
examed the extent of CD4 + cell activation following an acute infection with 
either
LCMV , VV, PV , or MCMV by determinng the percentage of CD4
CD44 cells in the
spleen at various days p.i. The mean percentage of CD4+
CD44 i cells from 6 individua
mice per group were as follows: day 0: 22::4; LCMV day 7: 
18::6; LCMV day 9:32::7;
VV day 7: 30::5; VV day 9: 27::4; PV day 7: 20::5; PV day 9: 24::5; 
MCMV day 7:
37::11; MCMV day 9: 38::11. Thus, each of these viruses induce 
CD4+ T cells
expressing an activated phenotype.
B. Increased frequency of IFN-'Y protein and IFN-'Y-secreting cells 
following a
heterologous virus infection. Our laboratory has previously 
shown that memory
CD8+ T cells from a previous viral infection can be stimulated by heterologous 
viruses
(Selin et al., 1994; Selin and Welsh, 1994; Welsh et al., 1996), and I questioned here 
how
challenging immune mice with heterologous viruses would 
infuence cytokine productio
LCMV - immune mice were challenged with VV , and the amount of IFN -
'Y in the peritoneal
fluid was measured by ELISA at day 3 p.i. with VV, a period in which there should be
107
little contribution from naive T cells responding to the acute virus infection. 
As can be
seen in Figure V- , infection of LCMV-immune mice with VV (16, 115:\14
766 pg/ml)
resulted in a :;1 074-fold increase in IFN-'Y protein levels in the peritoneal fluid at day 3
pj. as compared to naive mice (~15 pg/ml) or LCMV-immune mice ( 15 pg/ml), or a 5.4-
fold increase in comparison to control-immune mice acutely infected with 
(2,979:\3,600 pg/ml). LCMV-immune mice challenged with PV or VV-imune 
mice
challenged with LCMV did not exhibit ths enhanced production ofIFN-'Y (
15 pg/ml).
Furher examination of the peritoneal cavity using F ACS analysis revealed a signficant
recruitment of CD8+ (8-fold) and CD4+ (2A-fold) T cells into this comparment in
LCMV -immune versus control-immune mice 3 days pj. with VV (Fig. V -
3). In addition
most of the recruited cells were CD44 , consistent with an 
activated and/or memory
phenotype. I also examed the peritoneal cells for the expression of intracellular IFN-
following stimulation with PMA and ionomycin. Figure V-
3 shows that LCMV-immune
mice challenged with VV exhbit a significant (p~0. 01) increase in the number of IFN-
'Y-
producing CD8+ (10-fold) and CD4+ (2. fold) T cells at 3 days pj. as compared to
control-immune mice challenged with VV. Experiments performed by Dr. L.K. Selin have
shown that LCMV -immune mice have 10- to 300-fold lower VV titers in the spleen, fat
pad, and liver 3-5 days p.i. with VV (Selin et aI., 1998). cell depletion experiments
demonstrated that both CD4+ and CD8+ T cells were required to mediate this reduction in
virus titers. Moreover, it was shown that LCMV -immune mice genetically deficient in
108
vv Day 
50000
40000
30000
20000
10000
Control LCMV Imm.
Figure V -2. Increased IFN-'Y protein levels in peritoneal lavage fluid of
LCMV- immune mice versus control-immune mice 3 days after challenge with VV.
Peritoneal lavages were performed and IFN-'Y protein was quantitated using an
Endogen mouse IFN-'Y ELISA kit as per the manufacturer s instructions. IFN-
protein levels from 3 separate experiments with 4 individual mice per experiment are
shown (n=12 per group). There was a statistically significant difference between
the amount of IFN-'Y protein detected in the peritoneum of LCMV -immune as
compared to control-immune mice 3 days after VV infection (p~0.01).
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IFN-
'Y receptors failed to protect against VV infection but were stil able to protect aaainst
PV infection (Selin et aI. , 1998). Thus, these experiments demonstrate that both CD8+
and CD4+ memory T cells are recruited to produce IFN-'Y in LCMV- immune mIce
challenged with VV , and are able to offer enhanced protection by reducing VV titers early
after infection.
C. LCMV-specific CD4+ Thp frequency does not decline following multiple
heterologous virus infections. The above experiments suggest that CD4 + cells
become activated during each of these virus infections and in some cases, the memory
CD4 + T cells may playa role in mediating increased resistance to a heterologous virus
infection. Recent work from our laboratory has shown that heterologous virus infections
can have a profound impact on CD8+ T cell memory pool by causing reductions in the
CD8+ CTLp frequency to earlier virus infections (Selin et aI., 1996). Here I wanted to
ask the question of whether or not heterologous virus infections caused a similar
perturbation in the memory CD4+ T cell compartment. Having already established a CD4
LDA method for measuring LCMV -specific CD4+ Thp and shown that the LCMV-
specific CD4+ Thp frequency remains quite stable into long-term immunity (see Table
IV - 1), I examed the LCMV -specific CD4 + Thp frequency after 1-3 heterologous virus
infections. Figure V -4 shows that the LCMV -specific CD4 + Thp does not decline
following multiple heterologous virus infections (PV, VV, and MCMV). In addition, in
LCMV Imm.
LCMV+PV Imm.
LCMV+PV+VV+MCMV Imm.
LCMV Imm.
LCMV+PV Imm.
LCMV+PV+VV+MCMV Imm.
LCMV Imm.
LCMV+PV Imm.
LCMV+PV+VV+MCMV Imm.
100 1000
III
CD4
G2 CD8
10000
Thp or CTLp/50 000 T Cells
Figure V -4. Reduction of CD8+ CTLp but not CD4+ Thp following challenge of
LCMV -immune mice with several heterologous virus infections. CD4 LDA were
performed as described in the Materials and Methods on pooled spleen cells (3-
mice) from mice immune to each of the viruses listed. The results shown represent
3 individual experiments in which each group of mice was sampled within the same
LDA. In one experiment, the CD8+ CTLp frequency was determined from the
same mice by Dr. LX. Selin.
, "
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one of these assays , a CD8 LDA was performed by Dr. L.K. Selin in order to show that
within these mice, the LCMV -specific CD8+ CTLp frequency does decline as she has
previously reported (CD8+ CTLp " declined 6-fold in LCMV+PV- immune mice and 18-
fold in LCMV+PV+VV+MCMV-immune mice as compared to LCMV- immune mice).
Figure V-5 shows similar results quantifying LCMV-specific CD4+ Thp and CD8+ CTLp
in mice previously immunized with PV (PV+LCMV- immune mice) as compared to
PV +LCMV + VV +MCMV -immune mICe (CD8+ CTLp declined fold
PV+LCMV+VV+MCMV-immune mice as compared to PV+LCMV-immune mice). 
performed additional experiments using the LCMV MHC class II-restricted CD4
peptides in order to follow the fate of the peptide-specific CD4+ Thp under these same
conditions. Table V- I shows 3 independent experiments in which there is no significant
decline in the LCMV -specific CD4+ Thp frequency to whole virus or to either of the two
LCMV MHC class II-restricted CD4 peptides.
In order to exame if the order of the virus infections played a role, I performed
similar experiments using two other virus sequences. Table V -2 shows, using
PV+LCMV+VV+MCMV- immune mice, a similar lack of CD4+ Thp reduction to that
discussed above for LCMV+VV+PV+MCMV-immune mice. Interestingly, Table V-
shows , using VV+LCMV+PV+MCMV-immune mice that there is a slight drop (2-fold)
in the LCMV-specific CD4+ Thp frequency to each of the LCMV MHC class II-
restricted CD4 peptides in the first experiment and to the whole virus and to the peptides
PV+LCMV Imm.
PV+LCMV+VV+MCMV Imm.
PV+LCMV Imm.
PV+LCMV+VV+MCMV Imm.
PV+LCMV Imm.
PV+LCMV+VV+MCMV Imm.
113
CD4
CD8
100 1000 10000
Thp or CTLp/50 000 T Cells
Figure V-5. Reduction ofCD8+ CTLp but not CD4+ Thp following challenge of
PV+LCMV-immune mice with several heterologous virus infections. CD4 LDA
were performed as described in the Materials and Methods on pooled spleen cells
(3-4 mice) from mice immune to each of the viruses listed. The results shown
represent 3 individual experiments in which each group of mice was sampled within
the same LDA. In one experiment, the CD8+ CTLp frequency was determined from
the same mice by Dr. L.K. Selin.
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in the second experiment, in comparison with VV+LCMV-imune mice. However
interpretation of this drop is more problematic for the CD4+ Thp than for the CD8+
CTLp because, as is demonstrated in all these experiments, immunization with multiple
viruses results in higher background values against uninfected APC, even though each
virus has been either highly diluted in PBS or purified over sucrose gradients. These
results reinforce my earlier observations concernng the contribution of contamnating
antigens in the virus preparations and show how even small contaminants may elicit
measurable CD4+ T cell responses. Nonetheless, in contrast to the stable LCMV -specific
CD4+ Thp frequency observe LCMV+PV+VV+MCMV-
PV+LCMV+VV+MCMV-immune mice, VV+LCMV+PV+MCMV-immune mIce seem
to exhbit a slight drop in the LCMV-specific CD4+ Thp frequency as compared to
VV+LCMV-immune mice. These results show that, even though the CD8+ CTLp
frequency to earlier infections drops significantly following multiple heterologous virus
infections , the CD4+ Thp frequency remains fairly stable.
LCMV -specific CD4+ Thp . frequency following protein antigen
immunization. The above results show that the LCMV-specific CD4+ Thp, unike the
CD8+ CTLp, remain quite stable following multiple heterologous virus infections. Several
reasons may account for why we observe a decline in the CD8+ CTLp and not in the
CD4+ Thp frequency in this system. One possibility is that the CD4+ T cells are more
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cross-reactive between these viruses than the CD8+ CTL. The activation of virus-specific
memory T cells via cross-reactivity seems to protect these cells from the deletion that
occurs of the memory T cells specific to earlier viruses (L.K. Selin and R.M. Welsh
unpublished observations). The participation of memory CD4+ T cells to the increased
IFN-'Yproduction followingVV infection of LCMV-immune mice would seem to support
this notion (Fig. V -3). In addition, in two separate experiments there were elevated
LCMV-specific CD4+ Thp frequencies in PV-imune mice stimulated with LCMV-
infected PEC as APC (Experiment 1 :1/2 390; Experiment 2: 1/3 946) as compared to PV-
imune mice stimulated with mock-infected PEC as APC (Experiment :113 956;
Experiment 2: 1/8 601). I also observed a much higher LCMV -specific CD4+ Thp
frequency in four of six experiments using PV+LCMV-immune mice (Fig. V-5 and Table
2) as compared to LCMV-immune mice alone (Tables IV- 1 and IV-3), suggesting that a
PV infection may prime for LCMV -specific CD4+ Thp. These observations suggest that
heterologous virus infections are capable of activating memory CD4+ T cells , possibly
due to cross-reactivity.
Another possible reason why there is no decline in the CD4+ Thp frequency following
multiple heterologous virus infections is that none of these virus infections induce as
strong a CD4+ as a CD8+ T cell response. However, it should be noted, as I have shown
in Chapter IV , that :;10% of the CD4+ T cells score as virus-specific during infection with
LCMV , a virus previously thought not to stimulate strong CD4+ T cell responses. Even
119
less is known about the magnitude of the CD4+ T cell response to each of the other
viruses used here. In order to address this issue, I examed the LCMV -specific CD4 
Thp frequency in LCMV -immune mice challenged with one or two consecutive protein
antigens in adjuvant in an attempt to induce as strong a CD4+ T cell response as possible.
Table V -4 shows that LCMV -immune mice challenged with the complex protein antigen
KLH in adjuvant (CFA) does not reduce the LCMV-specific CD4+ Thp frequency to
whole virus or either of the two MHC class II-restricted peptides. Even an additional
immunization with the protein antigen OVA in a different adjuvant (TiterMax Gold)
failed to reduce the LCMV-specific CD4+ Thp frequency (Table V-5). A measurable
protein-antigen specific CD4+ Thp frequency was detectable in each of these
experiments, demonstrating that each of these immunizations efficiently stimulated a
CD4+ T cell response. These results suggest that even in the face of a strong CD4+ T cell
stimulus , the LCMV -specific CD4+ Thp frequency remains quite stable.
E. Intracellular staining of peptide-specific IFN-
'Y- producing CD4+ T cells
following multiple heterologous virus infections. In experiments presented 
Chapter IV, I show that LCMV -specific CD4 + T cells can be detected following
stimulation with peptide and IL-2 by staining for intracellular IFN-'Y production and, after
the virus has been cleared and the immune system returns to homeostasis , the percentage
of CD4 + T cells that stain IFN remains stable into long-term immunity. Here I
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I - questioned if the frequency of LCMV-specific IFN-'Y- producina CD4+ T cells also remai
stable following heterologous virus infections, as I have just demonstrated above using the
IL- based CD4 LDA. In several experiments, all done using some of the same mice
utilized above in the CD4 LDA , the intracellular IFN- 'Y assay mirrored the results of the
IL- based CD4 LDA, except that the frequencies of antigen-specific cells were in 
cases much higher for reasons already discussed in Chapter IV (see Table V -6). Thus, for
LCMV+PV+VV+MCMV- and PV+LCMV+VV+MCMV-immune mice, there was no
significant reduction in the frequency of CD4+ T cells that produced IFN-'Y following
stimulation with either of the two LCMV MHC class II-restricted CD4 peptides.
Interestingly, as the LDA results suggested above , I did observe a slight, but signficant
(p~0.05), 2-fold reduction in the frequency of CD4+ T cells that produced IFN-'Y in
VV+LCMV+PV+MCMV- immune mice as compared to VV+LCMV- immune mice (Table
V -6). These results support the CD4 LDA results discussed above suggesting that the
LCMV-specific CD4+ Thp frequency remains relatively stable following multiple
heterologous virus infections. These results also clearly demonstrate that, even though
the intracellular IFN- 'Y assay detects a higher frequency of virus-specific CD4+ T cells, it
mirrors any differences observed in the virus-specific CD4+ Thp frequencies obtained
using the IL- based CD4 LDA.
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F. Intracellular staining of cytokine-producing CD4+ T cells following acute
LCMV, PV, VV, or MCMV infection. As mentioned above, one reason for the observed
differences in the stability of the CD.8+ versus the CD4+ T cells followig heterologous
virus infections may be the degree to which each virus activates CD4 + T cells as
compared to CD8+ T cells. Each of these viruses are known inducers of CD8+ CTL. In
order to exame the extent to which each of these viruses activate CD4+ T cells, I
performed intracellular IFN -
'Y stainig on CD4 + T cells following PMA and ionomycin
activation from naive mice challenged with each of the four viruses used in these
experiments. As can be seen in Figure V - , each of the viruses stimulates increased
frequencies of CD4 + T cells capable of makg IFN-'Y when nonspecifically stimulated
with PMA and ionomycin. This , combined with the upregulation of activation markers
discussed earlier in this chapter, suggests that each of these viruses are capable of
activating a virus-specific CD4+ T cell response. However, it is difficult to accurately
measure the relative magnitude of the virus-specific CD4+ T cell response to PV, VV, or
MCMV without having any of the MHC class II-restricted CD4 epitopes.
G. Brief summary to Chapter V. Together, the data presented in this chapter show
that memory CD4+ T cells are capable of participating in heterologous T cell-mediated
immunity though the increased production of cytokines such as IFN-'Y following a
heterologous virus infection (Selin et aI. , 1998). However, unlike CD8+ T cells, CD4+
DavO
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LCMV Day 9 VV Day 9
17% 12%
PV Day 9
IFN-
CD4
MCMV Day 9
16%
Figure V-6. Intracellular IFN-'Y expression of virus-induced CD4+ T cells following stimulation with
PMA and ionomycin. Splenocytes from uninfected (day 0), or infected with LCMV , VV , PV , or MCMV
for 9 days were stimulated with PMA and ionomycin for 2 hr before the addition of brefeldin A for an
additional 2 hr as described in the Materials and Methods. The numbers shown indicate the percentage of
CD4+ T cells that stained positive for intracellular IFN-'Y as represented by the R1 gate. Data are
representative of 2 experiments with 2 individual mice per experiment (n=4 per group).
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Thp frequency is resistant to reduction by heterologous VIruS infections, even under
conditions that reduce the LCMV -specific CD8+ CTLp frequency (Selin et al. , 1996).
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CHATER VI
EXHUSTION OF LCMV-SPECIFIC CD4+ T CELLS
FOLLOWJNG HIGH DOSE LCMV JNFECTION
The last two chapters provide evidence that the LCMV -specific CD4+ Thp frequency
remains extremely stable even under conditions that reduce the LCMV -specific CD8+
CTLp frequency. Infection of mice with a high-dose of LCMV Clone 13 , a highly
disseminating variant capable of rapidly growing to high titers in all of the peripheral
organs, results in the transient activation, followed by exhaustion and clonal deletion of
the virus-specific CD8+ CTL under the stress of the overwhelming viral antigen
environment (Moskophidis et aI., 1993). The fate of the virus-specific CD4 + T cells
under these conditions is not known. In this chapter I followed the fate of the LCMV-
specific CD4+ T cells USiIlg LDA and intracellular IFN-'Y stainig following peptide
stimulation. I wil show that, like the CD8+ CTL , there is a decline in the frequency of
detectable virus-specific CD4+ T cells following a high-dose LCMV infection.
Quantitation of the CD4+ Thp frequency following LCMV Clone 13
infection. Table VI-1 shows an analysis of the LCMV-specific CD4+ Thp frequency 
C57BL/6 mice following a high-dose LCMV Clone 13 infection. The LCMV -specific
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CD4+ Thp frequency peaked at day 10 p.i. at a frequency comparable to that obtained
after a low-dose LCMV Armstrong infection. However, unike my previous results with
LCMV Armstrong (see Table IV- I), the virus-specific CD4+ Thp frequency declined to
undetectable levels by day 15 p.i. with LCMV Clone 13. These results suggest that high-
dose LCMV Clone 13 infection induces the exhaustion of the CD4+ T cells.
Intracellular staining of peptide-specific IFN-'Y- producing CD4+ T cells
following LCMV Clone 13 infection. Using the IL- based LDA, the above results
suggest that a transient virus-specific CD4+ T cell response occurs following a high-dose
LCMV Clone 13 infection. I utilized the intracellular IFN -'Y assay described in Chapter
IV to follow the fate of the IFN-'Y-secreting CD4+ T cells under these same conditions.
Figure VI- 1 shows the percentage of peptide-specific IFN- CD4+ T cells using the same
mice used in the LDA above. The percentage of IFN- CD4+ T cells never attained the
percentage observed during LCMV Armstrong infection, but interestingly, the frequency
ofIFN-'Y-secreting cells induced by Clone 13 does not decline below detectable levels, as
observed above for the IL- producing cells measured in the LDA. Closer examination of
these stains revealed that all of the CD4+ T cells that stained brightest for IFN-'Y were
absent in the LCMV Clone I3-infected animals (Fig. VI-2). Analysis of several activation
markers on CD4 + T cells demonstrated that there was increased expression of TCR-
Day 7 Clone 
Day 10 Clone13
Day 15 Clone 
Day 10 Arstrong
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. GP61-
o NP309-328
Percentage ofCD4+ T cells
Figure VI- I. Intracellular IFN - 'Y expression of LCMV peptide-specific CD4 + T
cells following LCMV Clone 13 or Armstrong infection. Splenocytes from the
indicated days p.i. were stimulated with one of two LCMV MHC class
II-restricted peptides in the presence of IL-2 and brefeldin A for 5 hr, as
described in the Materials and Methods. Background staining with the
appropriate isotype-matched control mAb was subtracted from each individuaL
Means:! standard deviations for time points from one of three similar
experiments with 3 individual mice per experiment are shown (n=3 per group).
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Day 10 Arstrong Day 10 Arstrong
. R1
Day 10 Clone Day 10 Clone 
Isotype IFN-
Control
CD4
Figure VI-2. Intracellular IFN-'Yexpression of LCMV peptide-specific CD4+ T
cells from LCMV Clone 13 -infected C57BL/6 mice. Splenocytes from LCMV
Armstrong- or Clone 13- infected mice (both day 10) were stimulated with the
LCMV MHC class II-restricted peptide GP61-80 in the presence of IL-2 and
brefeldin A for 5 hr as described in the Materials and Methods. The numbers
shown indicate the percentage of CD4+ T cells that stained positive for
intracellular IFN-
'Y as represented by the R1 gate. Data are representative of3
experiments.
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Table VI-2. Expression of Activation Markers on CD4+ T cells During the
Acute LCMV Clone 13 Infection
Percentage of Gated CD4+ T Cells
Day P. CD25 CD44 CD62U CD69
Day 0 1 O:! 16:! 3 16:! 7 9:! 3
Day 10 Armstrong 11:! 2 37:! 5 47:! 9 11 :! 3
Day 10 Clone 13 14:! 1 32:! 4 49:! 4 19:! 4
Day 15 Clone 13 l6:! 2 43:! 3 47:! 7 26:! 7
Day 21 Clone 13 l7:! 2 38:! 7 41:! 5 26:! 4
Spleen cells were from mice either uninfected (day 0), infected with LCMV Armstrong
(day 10), or LCMV Clone 13 for 10, 15 , or 21 days. Cells were stained for expression of
CD4 and various activation markers as described in the 
Materials and Methods. Means:!
standard deviations for time points from 2 separate experiments with "3 individual mice
per experiment are shown (n=6 per group).
Indicates a significant difference as compared to day 0 p~0.05.
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dependent markers such as CD25 and CD69 throughout the time points examed (Table
VI-2). This demonstrates that, even though the IL- producing CD4+ Thp cannot be
detected, CD4+ T cells expressing activation markers are stil present in vivo and have not
been deleted.
Anexin V staining of CD4 + T cells was performed to exame whether there is an
increased frequency of CD4+ T cells undergoing apoptosis following LCMV Clone 13
expression. One of the earliest events in apoptosis is the translocation of the membrane
phospholipid phosphatidylserine to the outside of the plasma membrane. Annexin V is a
2+ -dependent phospholipid-binding protein that has high affinity for
phosphatidylserine. Table VI-3 shows that, there is a higher percentage of apoptotic
CD4 + T cells durg LCMV Clone 13 infection as compared to naive mice at all time
points tested. Thus, unike LCMV Armstrong infection, in which there is a peak in the
percentage of CD4+ T cells undergoing apoptosis once virus has been cleared, LCMV
Clone 13 infection seems to induce a steady rate of apoptosis in the CD4 + cell
population.
There are several reasons that might explain why the LDA fails to detect any Virus-
specific CD4+ Thp after day 15 pi. yet the intracellular stain can still score virus-specific
CD4+ T cells capable of makg IFN-'Y out to day 15 p.i. One reason is that the two
assays may be detecting mutually exclusive cell populations. Alternatively, as a result of
the high antigen environment, all of the CD4+ T cells may be driven into termnal effector
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Table VI-3. Increase in the Percentage of Apoptotic CD4+ T cells During
the Acute LCMV Infection with either Arstron or CIQne 13 
Percentage of Gated CD4 + T Cells
Day Post-Infection Anexin +
Day 0 8:t 5
Day 7 Armstrong 12:t 5
Day 9 Armstrong 20:t 8
Day 11 Armstrong 18:t 7
Day 15 Armstrong 14:t 5
LCMV Armstrong Immune 13:t 5
Day 0 5:t 2
Day 10 Armstrong 16:t 3
Day 10 Clone 13 ll:t 2
Day 15 Clone 16:t 3
Day 21 Clone 13 16:t 4
Spleen cells were from mice either uninfected (day 0), infected with LCMV Arstrong,
or LCMV Clone 13 for the indicated number of days. Cells were stained for expression
of CD4 and anexin V. The numbers shown represent the percentage of CD4+ T cells
that were also annexin V+ . Means:t standard deviations for time points from 2 separate
experiments with 3 individual mice per experiment are shown (n=6 per group).
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cells in which all of the cells are producing effector cytokines such as IFN-'Y with little
production of IL-2. Another possibility is that all of the high-affinity virus-specific
CD4 + T cells have been exhausted and what remains are low-affinity LCMV -specific
CD4-i T this would be consistent with the weakly staining IFN- + cells. Finally, it may
be that the CD4+ T cells may be anergic by day 15 p.i. and that the LDA, based on the
production ofIL- , fail to detect them, but the intracellular IFN-'Y assay, in which anergy
may be broken by the addition of exogenous IL-2 to assay, would be able to detect anergic
cells. Anergic T cells can be rescued by the addition of exogenous IL-2 in the presence of
antigen.
C. Brief summary to Chapter VI. I have shown in this chapter that a high-dose
LCMV infection alters the virus-specific CD4+ T cell response. I have provided evidence
that there is a decline in the detectable frequency of IL- producing CD4-i Thp 
detected using the CD4 LDA. In addition, I show that a large percentage of the CD4 + T
cells continue to express activation markers following LCMV Clone 13 infection and that
some of these CD4+ T cells are stil capable of makg IFN-'Y following stimulation with
peptide in the presence ofIL-2. These results suggest that the CD4+ T cells may become
anergic following a high-dose LCMV Clone 13 infection and are thus impaired in their
ability to produce IL-2 but can be rescued to make IFN-'Y in the presence of peptide and
exogenous IL-2. This interpretation would agree with a recent study demonstrating that
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LCMV -specific transgenic CD4+ T cells persist in vivo in an anergic state for :;6 weeks
following high-dose LCMV Docile infection (Oxenius et aI. , 1998).
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CHATER vn
DISCUSSION
I have made several novel observations in this thesis concerng the magntude
longevity, and stability of the CD4+ T cell response durng an acute virus infection and
into long-term memory. In addition to these findings, I have provided evidence that CZ-
, a new mAb created in our laboratory (Brutkiewicz et aI., 1993; Vargas-Cortes et al.
1992), represents a novel activation and memory marker on CD4+ T cells. I have also
shown that, in contrast to the conclusion of recent reports (Su et aI. , 1998; Whitme et
aI. , 1998), LCMV infection induces primarily a Th1 response characterized by increased
production oflL-2 and IFN-'Y by the virus-specific CD4+ T cells. Finally, I provide data
that suggest that the CD4+ T cells become unresponsive following a high-dose LCMV
Clone 13 infection. Taken together, the data presented in this thesis make several
important observations that help provide a better understanding of virus-specific CD4+ T
cell responses. Below is an in depth discussion of the major points made in this thesis.
A. Activation phenotype of CD4+ T cells and characterization of mAb CZ-l. As
I detailed in the introduction, T cell activation induces many changes in naive T cells
including alterations in the expression of several cell surface molecules. Most of these
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markers are expressed on both activated and memory T cells. One specific ai of this
thesis was to determine the magnitude of the virus-specific CD4+ T cell response
following an acute virus infection. I took advantage of the well-studied LCMV system 
begin to address this issue , as well as pose other fundanlental, yet unresolved, questions
concerng virus-specific CD4+ T cell responses. To begin to exame the magnitude of
the CD4+ T cell response following LCMV -infection, I utilized a panel of cell surace
markers to define activated CD4+ T cells and showed that by day 10 pj. with LCMV
there was an increase in the cell surface expression of activation markers such as CD44
CD49d, LFA- , and CZ- l on gated CD4+ T cells (Figs. 1II- , 1II- , and Table III- I).
Even though there was little increase in the absolute numbers of CD4+ T cells in the
spleen expressing these activation markers, there was an increase in the relative
proportion of CD4+ T cells expressing these activation markers (Figs. III-2 and III-3).
This is most likely because there is little to no expansion in the total number of CD4 + T
cells in the spleen during an acute LCMV infection (Fig. III-I). A simlar increase in the
proportion of CD4+ T cells expressing elevated cell surface levels of CD49d and CD62L
in the spleen following infection with the Traub strain of LCMV in Balb/c mice has been
previously described (Andersson. etaL , 1994). However, the percentage of CD4+ T cells
that remain in the spleen following infection with this strain of LCMV is even lower (6%)
than what I have observed here using LCMV Arstrong (10%, Fig. III-I). More recent
studies using LCMV Armstrong have reported similar percentages of CD4+ T cells
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expressing CD44 than what I have shown here (Whitme et al. , 1998). I also show that
25% of the CD4+ T cells in the spleen were blast-sized at day 7 p.i. and that 7% of the
CD4+ T cells were in the G2+M or S phase of the cell cycle. Agai, these data contrast
with a previous report demonstrating that only 2% of CD4-i T cells exhbited increased
DNA content following an acute infection with the Traub strain of LCMV in Balb/c mice
(Christensen et aI. , 1996). The discrepancy between these findings and mine may be due
to differences in the inecting dose of virus, strains of virus, or strains of mice that were
used in these studies. My results clearly show that a large proportion of the CD4+ T
cells express an activated cell phenotype following an acute LCMV infection.
Interestingly, the peak of expression of the very early activation antigen CD69
occurred at 2-3 days p.i. (Fig. III-4 and data not shown), well before the peak of the other
markers discussed above (Table III- I and Fig. 1II-4). This expression pattern parallels the
type I IFN response in these mice (Leist et aI. , 1987). To my knowledge, type I IFN has
not been previously reported to upregulate CD69 expression on CD4+ T cells, though it
has been shown to induce CD69 expression on NK cells (Testi et aI. , 1994). However
because I have not directly measured the amount of type I IFN in these anals, more
studies would need to be performed in order to establish that type I IFN can upregulate
CD69 expression on CD4+ T cells.
I present data in this thesis that shows that the sialated CD45RB-associated epitope
detected by mAb CZ- 1 is both an activation and a memory marker on virus-induced
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CD4 + T cells. MAb CZ- I identifies an antigen that appears late in the differentiation 
CD4+ T cells. It reacts with only 1% of the CD4+CD8- thymocytes (Vargas-Cortes et
aI. , 1992), and in contrast to CD8+ T cells, the CZ- 1 epitope is expressed on only a small
proportion of mature CD4-i T cells. However, its expression is increased on most
activated CD4+ T cells, including all of the IL-2-responsive CD4+ T cells (Brutkiewicz et
aI., 1993). Here I show that the mAb CZ- l heterogeneously stains CD4+ T cells in a
pattern distinct from that exhibited by anti-CD45RB (Ernst et aI. , 1990). When CD4+ T
cells from the spleens of mice undergoing an acute infection with LCMV were stained
with both mAb CZ- 1 and anti-CD45RB , a subpopulation of CZ- CD45RB cells
appeared (Fig. III -6). Further analyses of the cell surface phenotype durg the acute
infection with LCMV revealed that the blast-sized CD4+ T cells were CZ-
1 +CD45RB CD44 CD62L- (Fig. II-7 and 1II-8). Therefore, the CZ- 1 antigen was
upregulated upon CD4+ T cell activation. Since CZ- I recognizes a sialic acid-associated
epitope of CD45RB CD4 + T cells may begin sialating CD45RB molecules upon
activation. The increase in a CD45RB-associated epitope would seem at odds with the
observation that memory CD4+ T cells express lower levels of surface CD45RB
(Birkeland et aI. , 1989), but a conversion from non-sialated to sialated forms of the
molecule could account for the CZ- 1 staining patterns, even though the total protein
levels may be reduced.
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Experiments on the function of CD4+ T cell subsets separated by CZ- 1 indicate that
this antibody identifies a functionally distinct population of T cells. The CD4+CZ- 1 + T
cells contained all of the LCMV -specific memory. It was also shown that no memory
could be rescued from the CD4+CZ- 1- population, even in the presence of exogenous IL-
(Fig. III - 11). CZ- 1 expression can be upregulated by anti-CD3 or concanavalin A in non-
expressing CD4+ T cells and is expressed on all IL-2-responsive CD4+ T cells
(Brutkewicz et al. , 1993; Vargas-Cortes et aI., 1992). Currently, antibodies to CD45RB
are commonly used to distinguish naive and antigen primed/memory CD4 + T cells
(Bradley et aI. , 1993; Gray, 1993; Lee et aI. , 1990). However, unlike CD45RB , CZ- 1 is a
positive marker for CD4+ T cell memory in mice. In the LDA studies examg the
phenotype of the memory CD4+ Thp, CZ- 1 was better than most of the markers used
and at least as good as CD49d, for detecting LCMV -specific memory CD4+ T cells (Table
IV-4). Taken together, these data show that CZ- l represents a novel activation and
memory marker on murine CD4+ T cells.
B. Analysis of the cytokine response during LCMV infection. Another specific
aim of this thesis was to determine the cytokine profie induced following LCMV
infection. Recent work in several virus models, including LCMV, influenza virus , Sendai
virus, MHV -68, and HIV infection in humans has suggested that a mixtue of cells
secreting type 1 and type 2 cytokine profies are induced by the viral infection (Alonso et
aI. , 1997; Carding et al. , 1993; Meyaard et aI. , 1994; Mo et aI. , 1995; Sarawar et al. , 1996;
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Sarawar and Doherty, 1994; Su et aI. , 1998; Whitmire et al., 1998). However, few of
these studies have examed the relative contribution of CD4+ and CD8+ T cells to this
cytokine production followig an acute virus infection. Thus, there is little information
concerng the cytokine profile of CD4 + T cells that are induced following a virus
infection. In this thesis I have examed cytokine production using several different
techniques including ELISA, ELI SPOT assays, and new methods based on intracellular
cytokine staining following in vitro 
peptide stimulation. The latter assay in paricular
allowed me to examine both the type of cytokine-secreting cells elicited following LCMV
infection as well as to determine the magnitude of the virus-specific CD4 + T cell
response. Using ELI SPOT assays to detect individual cytokine-secreting cells, I
demonstrate that the frequency of IFN-'Y-secreting cells in the spleen peaked by day 9
pj.
, in general agreement with previous work by Gessner et al. using simlar assays
following LCMV WE infection (Fig. III- 14 and (Gessner et aI., 1990; Gessner et aI.
1989). The frequency of IFN-'Y- producing splenocytes at day 7 p.i. was 10-fold higher
than that reported by Cousens et al. using the same strain of mice and virus, but her
assays were done in the absence of LCMV -infected APC (Cousens et aI., 1995).
Interestingly, the frequencies of IFN 'Y- 
and IL- producing cells reported by this group
are almost identical to those shown in Table 1II-2 using virus contaminated with FCS
antigens (Cousens et aI., 1995; Su et al., 1998). In addition, I have failed to detect any
significant IL-4 production following assay of conditioned media or following in vitro
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restimulation with the LCMV MHC class II-restricted CD4 peptides. 
This suggests that
some of the recent reports of Th2 responses durg LCMV infection may be 
inaccurate
due to FCS antigens present in the virus preparations (Su et aI., 1998; 
Whtme et aI.,
1998). This idea is further supported by later experiments showing that no LCMV-
specific CD4+ Thp could be detected by LDA using the very IL-
4-sensitive CT.4S cell
line. Furthermore, intracellular cytokine staining following polyclonal stimulation with
PMA and ionomycin revealed no increase in the frequency of IL-
producing cells durg
an acute LCMV infection (Fig. IV -2). Likewise , I could detect no increase in intracellular
IL- , IL- , or IL- l 0 levels following LCMV infection, even in mice genetically deficient in
CD8+ T cells that mount a very strong virus-specific CD4+ T cell response following
LCMV infection (Fig. IV -6). Work by other groups have failed to detect increases in IL-
production following LCMV infection, including a recent study using a transgenic CD4 
T cell specific for the GP6l-80 epitope of LCMV (Homann et al., 1998; Oxenius et aI.,
1998; Oxenius et al. , 1996). Thus , LCMV infection induces cytokine production that is
consistent with a polarized Th1 phenotype. It remains to be seen whether the IL-
production reported in other virus systems is also the result of T 
cell responses to
nonviral antigens as I have shown here for LCMV.
The above experiments I performed did not address what cells 
were responsible for
making the IFN-y. F ACS-purification of CD4+ and CD8
;- T cells revealed that there were
consistently more CD8+ than CD4+ T cells secreting IFN-'Y cells 
durg the acute LCMV
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J _ infection, as detected at the single-cell level utilizing the ELI SPOT assay. This ratio - is
not surrising, given that later experiments will demonstrate that there are approximately
7- to 10-fold more CD8+ CTLp than CD4+ Thp at these time points durng the acute
LCMV infection (Table IV- I and (Selin et aI. , 1996)). Interestingly, in 4 independent
experiments, the CD4+ and CD8+ Tcells secreted comparable amounts of IFN-'Y protein
into the supernatant even though . there were many more IFN-'Y-secreting CD8+ T cells
than CD4+ T cells as detected by ELI SPOT assays (Table III-3). This observed
difference may be explained by fact that LCMV infection induces CD8+ CTL with high
cytotoxic activities that may be capable of destroying virus-infected APC and thus
reducing the amount of IFN-'Y that is produced by the CD8+ CTL (Planz et aI. , 1996).
However, this seems unlikely given that the number of LCMV -infected APC used in
these assays is in great excess over the frequency of responding CD8+ T cells. Of interest
is that recent studies have found that CD8+ CTL clones with high cytotoxic activity
produced low amounts of cytokines (Sad et aI., 1996). Thus , these results suggest that
CD4+ T cells make more IFN-'Y on a per cell basis, than CD8+ T cells durng an acute
LCMV infection. This conclusion is also consistent with the relative intensity of IFN-
staining we observe in the intracellular IFN-'Y assay using either CD4+ or CD8+ T cells. 
this assay, the CD4 + T cells often demonstrate a higher intensity of IFN -'Y staining that
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the CD8+ T cells. Taken together, these data show that LCMV infection induces CD4+ T
cells with predominantly a Thl phenotype.
C. Detection of a high frequency of LCMV-specific CD4+ T cells. Another
specific aim of this thesis was to determine the magnitude of the LCMV-specific CD4+ T
cell response following acute LCMV infection. Examation of the CD4 + Thp frequency
using the IL- based LDA during an acute LCMV infection and on into the memory state
revealed that within 10 days p.i. with LCMV, the CD4+ Thp frequency rose from
~11l00 000 to approximately 11600 (Table IV- I).
. Quantitation of virus-specific CD4+
Thp frequencies using LDA in several other virus systems has yielded CD4+ Thp
frequencies that range from 11300 to 1/2000 from the peak of the acute response into
long-term memory (Ewing et aI. , 1995; Topham and Doherty, 1998; Topham et aI. , 1996;
Tripp et aI. , 1997). Thus, even though 25% of the CD4+ T cells are blast-sized at day 7
p.i. and 25-50% of the CD4+ T cells express activation markers, ~1 % of these cells scored
in LDA as being virus-specific. Using new sensitive assays to measure IFN-
'Y production
at the single-cell level, I show that:; 20% of the CD4 + T cells secreted IFN -'Y after
poly clonal stimulation with PMA and ionomycin (Fig. IV - 2), and :;10% of the CD4 + T
cells secreted IFN-'Y after stimulation with either of the two LCMV MHC class II-
restricted peptides (Fig. IV -5). The total number of virus-specific CD4+ T cells may be
even higher than I show here, since only two CD4 peptides were used. It is likely that
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the CD4+ T cell response to LCMV includes other MHC class II-restricted epitopes
which have yet to be identified. Thus, these new sensitive assays reveal a previously
unappreciated profound antigen-specific CD4 + T cell response during viral infections.
Because LDA could only account for a few percent of the T cells as being virus-
specific (Asano and Ahmed, 1996; Butz and Bevan, 1998; Murali-Krshna et aI., 1998;
Selin et aI., 1996; Varga and Welsh, 1998), it had been suggested that bystander
activation of the T cells by cytokines released during the virus infection might account for
the vast majority of the responding T cells (Tough et aI. , 1996; Tough and Sprent, 1996).
However, the data presented here, in conjunction with recent studies examg the
specificity of the CD8+ T cells (Butz and Bevan, 1998; Murali-Krshna et aI., 1998;
Zarozinski and Welsh, 1997), argue that most of the T cells being activated durg 
acute LCMV infection are indeed virus-specific.
D. Stabilty of LCMV-specifc CD4+ Thp into long-term immunity. Determng
the longevity of CD4 + cell memory following an acute virus infection was another
specific aim of this thesis. Agai I have made use of several different assays to exame
this important issue. Using CD4 LDA based on IL- production, I show that the
frequency of LCMV -specific CD4 + T cells within the CD4 + T cell pool remains
remarkably constant from the peak in the acute viral infection and throughout long-term
memory. Using this assay, the CD4+ Thp frequencies one year after infection are only 2-
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fold lower than their peak at day 1 0 p.i. This result mIrrors recent work from our
laboratory that has shown that the frequency of LCMV -specific CTLp per CD8+ T cell
drops only 2-fold from its peak, as the acute LCMV infection converts into a memory
state (Selin et al. , 1996). This 2-fold drop per CD8+ T cell occurs durng the more global
5 to 10-fold drop in the total CD8+ T cell . number per spleen, as the immune response
silences and the CD8/CD4 ratio converts from 2: 1 to 1 :2 , as shown in Figure III - 1. A
similar observation has been made in an LCMV -specific CD8+ TCR transgenic model
, in
which the frequency of adoptively transferred transgenic T cells reached 70% of the
CD8+ T cells durng the peak of the acute infection and remained at 27% in the memory
state (Zimmermann et al., 1996). However, I observe a slightly larger 2- to 7-fold drop in
the CD4+ Thp frequency when peptides are used as the stimulus in the CD4 LDA 
(Table
IV-3). Likewise , using the intracellular IFN-'Y assay, the percentage of CD4+ T cells that
are LCMV peptide-specific declines 5- to 7-fold from the peak of the response into long-
term immunty (Fig. IV -5). This agrees with the results I obtained in the LDA using these
two peptides but contrasts with the consistent 2-fold drop I observe in the LDA 
using
whole virus as discussed above. This discrepancy may be due to the detection of lower
affinity Tcells following peptide stimulation as compared to using whole virus.
Studies following the fate of protein antigen-specific transgenic CD4+ T cells 
have
observed large 20- to 40-fold reductions in the total number of transgenic CD4
+ T cells
following protein antigen immunization as the immune system returns to 
homeostasis.
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Recent work in the influenza and Sendai virus systems have also reported larger 5- to 10-
fold reductions in the virus-specific CD4 + Thp from the peak of the acute response into
memory (Dohert et aI., 1996; Ewing et aI. , 1995; Topham et al. , 1996). In addition
recent studies examg LCMV -specific CD8+ T cell frequencies using MHC class 
tetramers loaded with immunodominant viral peptides or intracellular IFN -'Y stainig
following viral peptide stimulation have also shown approximately 6-fold reductions in
the virus-specificCD8+ T cell frequency from the peak of the acute response into
memory (Butz and Bevan , 1998; Murali-Krishna et aI., 1998). Thus, studies performed in
a variety of systems have reported variable drop-offs in the frequency of antigen-specific
T cells from the peak of the response into memory.
It is curently unclear why these new assays detect such a higher frequency of virus-
specific T cells than can be detected using LDA. The efficiency of the LDA is
understood to be less than 100% , and it may be that LDA vastly underestimate the
frequency of virus-specific T cells at the peak of the acute virus infection. In the case of
the LDA for CD8+ CTLp, this assay requires the T cell to not only proliferate under 
vitro stimulation conditions, but then to kill virus-infected target cells. Thus, this assay
would fail to score any virus-specific CD8+ T cell that is not cytotoxic, such as virus-
specific CD8+ T cells that may be involved in predominantly secreting cytokines as
opposed to kiling infected cells. Thus , this may account for why staining of Tcells using
these other techniques based on cytokine production or TCR specificity yields a much
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higher frequency of virus-specific T cells than the LDA (Butz and Bevan, 1998; Mural-
3__-
-,-
Krishna et aI., 1998). As for the CD4 LDA, a simlar problem may exist, as stimulation
with the CD4 peptides may be able to activate lower affinity virus-specific CD4+ T cells
that are not detected by stimulation with the whole virus. However, even though I
observe a slightly larger drop in the virs-specific CD4+ Thp frequency following peptide
stimulation, once virus has been cleared, both the IL- based LDA and the intracellular
IFN-'Y assay reveal that the LCMV peptide-specific CD4+ T cell frequency remains
remarkably stable in the memory state for essentially the life-time of the mouse (Table
IV- , Table IV- , and Fig. IV-5).
E. Role of CD4+ T cells during heterologous virus infections. Ongoing work in
our laboratory suggests that memory T cells can be important mediators in the early
immune response of immune mice challenged with a heterologous virus (Selin et aI., 1998;
Welsh et aI., 1996). Putatively unelated viruses that do not normally induce cross-
reactive CD8+ CTL responses will elicit cross-reactive responses if mice imune to one
virus are challenged with another. Presumably a subset of memory CD8+ CTL clones
specific to the first virus cross-reacts sufficiently with the second virus to be stimulated
and amplified in number (Selin et aI., 1994; Selin and Welsh, 1994). A specific ai 
this thesis was to determine if memory CD4+ T cells could playa role in contrbuting to
heterologous T cell immunity. I demonstrate that CD4+ T cells are also capable of
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responding early (day 3) during a heterologous viral inection by secreting IFN-'Y (Figs. 
2 and V-3). Our laboratory has reported that early memory CD8+ T cell responses can
mediate a reduction in virus replication followig challenge with heterologous viruses
(Welsh et aI. , 1996), but work performed more recently in collaboration with Dr. L.K.
Selin suggests that this protection may involve the combined efforts of both memory
CD4+ and memory CD8+ T cells (Selin et aI., 1998). It has been shown that memory T
cells are capable of secreting high quantities of cytokines (Bradley et aI., 1993). Thus
one possible mechanism by which CD4+ T cells may act early durng a heterologous viral
infection is through the secretion of cytokines such as IL- , IFN 
'Y, or TNF -a, which
could in tur activate and amplify the number of cross-reactive memory CD8+ CTL to
lyse virus-infected targets. In addition, the CD4+ T cells may mediate direct anti-viral
effects through their production ofIFN-'Y and TNF-a. Cytokines may play an important
role in protection against viruses such as VV and MCMV , as these viruses are known to
be very sensitive to IFN-
'Y (Muller et aI. , 1994; Orange and Biron , 1996; VanDen Broek et
aI. , 1995).
It has been known for many years that immunologically naive hosts respond poorly to
antigens, but I believe that my observations reflect specificities in responses rather than
simply an increased pool of memory T cells ready to be nonspecific ally stimulated. 
could not detect any enhanced cytokine production by memory T cells from LCMV-
inune mice challenged with PV - or from VV -immune mice challenged with LCMV.
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Thus , the frequency of cytokine-producing cells was dependent both on the virus-specific
immune status of the animal as well as the paricular challenge virus.
Cross-reactive T cell responses have now been described in several different systems
ranging from in vitro work with T cell clones stimulated with altered peptide ligands 
to 
vivo models showing cross-reactive T cells between two bacterial proteins or between
unrelated viruses (Evavold et aI. , 1995; Haris et aI., 1995; Selin et aI., 1994). Additional
work has shown that peptides with mial primary sequence identity can elicit cross-
reactive T cell responses (Hagerty and Allen, 1995; Wucherpfennig and Strominger,
1995), and in some cases alteration of the peptide can result in fuctionally different T
cell responses, such as cytokine secretion and/or cytolytic responses in the 
absence of
proliferation (Evavold and Allen, 1992; Evavold et al., 1993; Evavold et aI., 1993;
Hollsberg et aI., 1995). Our laboratory s demonstration by LDA of cross-reactive
memory CD8+ CTL suggests that cross-reactive memory CD4+ T cells may also
proliferate in some of these cultures (L.K. Selin and R.M. Welsh, unpublished
observations). Interestingly, I have observed increased LCMV CD4+ Thp frequencies in
PV+LCMV-immune mice as compared to LCMV-immune mice in four of six LDA.
Taken together, these observations suggest that the production of cytokineselicited by
heterologous viral infections may be due to cross-reactive memory CD4
+ T cells.
However, this has yet to be formally proven in LDA assays.
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In experiments examg the fate of the LCMV -specific CD4 + Thp cells following
multiple heterologous virus infections, I show that heterologous virus infections have
little impact on the stable LCMV -specific CD4+ memory T cell pooL Thus , the memory
CD4 + Thp frequency is resistant to reduction by heterologous virus infections, even
under conditions that reduce the LCMV-specific CD8+ CTLp frequency (Selin et aI.
1996). Several reasons may account for why we observe a decline in the CD8+ CTLp but
not in the CD4+ Thp frequency in this system. One possibility is that the CD4+ T cells
are more cross-reactive between these viruses than the CD8+ CTL. The activation of
virus-specific memory T cells via cross-reactivity seems to protect these cells from the
deletion that occurs of the memory T cells specific to earlier viruses (L.K. Selin and R.
Welsh, unpublished observations). The participation of memory CD4+ T cells to the
increased IFN-
'Y production following VV infection of LCMV-immune mice would seem
to support this notion (Fig. V-3). Moreover, I have noticed enhanced LCMV-specific
CD4+ Thp frequencies in PV-immune mice, further suggesting that CD4+ T cells may be
cross-reactive between some of these viruses. Another, more likely, possibility is that
none of these virus infections induces as strong a CD4+ as a CD8+ T cell response. Even
though, I have shown in Chapter IV that :;10% of the CD4 + T cells score as virus-specific
during infection with LCMV , a virus not thought of as a strong inducer of CD4+ T cells.
The CD4 population does not expand in number like the CD8 population, which has to
be substantially compressed after an infection. The LCMV-specific CD4+ Thp
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frequency remained stable even after several protein antigen immunizations. One reason
for this dichotomy between the CD8+ and CD4+ T cells may be the large difference in
precursor frequencies generated following these virus infections (Selin et al. , 1996; Varga
and Welsh , 1998; Varga and Welsh, 1998). It may be that all of the available CD8+ T cell
memory pool is filled after each infection, and therefore memory cells to earlier infections
must be deleted to make room for the newly generated memory cells to the most recent
infection. Since there are approximately 7- to 10-fold fewer CD4+ Thp that CD8+ CTLp
(Murali-Krishna et aI., 1998; Varga and Welsh, 1998), it may be that the CD4+ T cell
memory pool has not become full following just 4 virus infections. Thus , there would be
no need to delete any memory T cells from earlier infections. In addition, there is a large
expansion in CD8+ T cell numbers following each of these virus infections, and once virus
has been cleared, the immune system must return the T cell numbers back to homeostasis
through activation induced cell death of the activated T cell population. Durng this
contraction phase following a virus infection, memory T cells specific to previous viruses
may become sensitized to die in this apoptotic environment.
These experiments also show that the CD4+ and CD8+ memory T cell pools are
regulated independently. In experiments performed in collaboration with Dr. L.K. Selin
we show that the LCMV -specific CD4+ Thp remains stable in mice that reduce the
LCMV -specific CD8+ CTLp following heterologous virus infections (Figs. V - , V -5 and
(Selin et aI. , 1996)). It is currently unclear what mechansm drives this deletion of
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memory CD8+ T cells. However, these experiments demonstrate that whatever the
mechansm is, it deletes the virus-specific CD8+ T cells without affecting the CD4+ T
cells. This suggests that different signals may regulate the size of the CD8+ and CD4 + T
cell memory pools.
The resistance of the LCMV -specific memory CD4 + T cell pool to deletion following
heterologous virus infections may playa role in preserving the remaig virus-specific
CD8+ CTLp. Protection against each of the viruses used here is dependent on MHC
class I-restricted CD8+ CTL , which can fuction independently ofCD4+ T cells to mount
a protective response. However, recent work has suggested that CD4+ T cells may playa
role in the maintenance of memory CD8+ CTL to viruses such as LCMV (V on Herrath et
aI., 1996). With data presented in this thesis, our laboratory has now shown that
LCMV -specific memory CD4+ and CD8+ T cells persist long after the initial infection
and that there is a continually cycling population of CD8+ CTLp (Razvi et al., 1995;
Varga and Welsh , 1998). This suggests that the continued presence of memory CD4+ T
cells may be required to maintain the continued cycling of a small frequency of memory
CD8+ CTLp. Thus, the maintenance of the CD4+ Thp frequency may help to maitain
the remaining virus-specific CD8+ CTLp to ensure long-term protective immunity. It is
currently unkown whether or not the maintenance of the CD4+ T cell memory pool
requires the presence of CD8+ T cells or some other cell population.
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F. Exhaustion of virus-specific CD4+ T cells. Many of the above experiments
clearly establish the stability of LCMV-specific CD4+ T cell memory. I have presented
data showing that the LCMV -specific CD4 + Thp frequency remains stable even under
conditions that result in the reduction of the LCMV -specific CD8+ CTLp frequency
(Selin et al. , 1996). Highly activated T cells are more susceptible than unstimulated cells
to undergo apoptosis when they receive continued stimulation through their cell
receptors (Razvi and Welsh, 1993). Infection of mice with a high-dose of LCMV Clone
13 has been shown to selectively delete the virus-specific CD8+ T cells by days 7-8 p.i.
due to the overwhelming virus infection (Moskophidis et aI. , 1993). The fate of the virus-
specific CD4 + T cells under these conditions was not known. In this thesis I have
provided evidence that there is a decline in the detectable frequency of IL- producing
CD4+ Thp as detected using the CD4 LDA (Table VI- I). In addition, I show that a large
percentage of the CD4+ T cells continue to express activation markers following LCMV
Clone 13 infection and that some of these CD4+ T cells are still capable of makg IFN-
following stimulation with peptide in the presence of IL-2 (Table VI-2 and Fig. VI-2).
These results suggest that the CD4 + T cells may become anergic followig a high-dose
LCMV Clone 13 infection and are thus impaired in their ability to produce IL-2 but can
be rescued to make IFN-'Y in the presence of peptide and exogenous IL- This
interpretation would agree with a recent study demonstrating that LCMV -specific
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transgenic CD4 + T cells persist in vivo in an anergic state for :;6 weeks followig high-
dose LCMV Docile infection (Oxenius et al., 1998).
Recent work examg HIV-infected humans has correlated decreased CD4+ T cell
responses with elevated viral loads (Rosenberg et al., 1997). Thus , the progressive loss
of virus-specific CD8+ CTL activity that occurs durg HIV infection seems to parallel
the decline in the CD4 + T cell numbers. The underlying mechansms by which CD4 + T
cells maintain CD8+ CTL during persistent viral infections are not well understood. The
CD8+ T cells may need cytokines , such as IL- , secreted by the CD4+ T cells in order to
surive and not become exhausted in the high antigen environment. Another possibility is
that CD4+ T cells sustain the activation of professional APC. CD4+ T cells promote the
activation of dendritic cells through the interaction of CD40-ligand, on the CD4+ T cell
and CD40 , on the dendritic cell. Recent work has suggested that dendritic cells playa
critical role in stimulating naive CD8+ T cells (Bennett et aI., 1998; Ridge et aI., 1998;
Schoenberger et aI. , 1998). Thus , durng persistent virus infection, CD8+ T cells may
need the CD4 + T cells to maintain the activation of the APC in order to continue the
priming of new CD8+ CTL. This point is supported by the observation that mice
genetically deficient in perforin do not c10nally exhaust as the CD8+ T cells canot
destroy virus-infected APC (Binder et al., 1998; Gallimore et aI. , 1998). A recent report
has shown that mice deficient in CD40-ligand fail to efficiently control LCMV after
apparent resolution ofthe acute infection, as virus would recrudesce several months after
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the initial infection (Thomsen et al. , 1998). Interestingly, the data I present here suggest
that the LCMV-specific CD4+ T cells functionally exhaust after the CD8+ T cells have
exhausted (Moskophidis et aI. , 1993), indicating that even in the presence of CD4+ T
cells, the CD8+ T cells may become activated so fully in this high antigen environment
that they are driven into activation induced cell death.
Conclusions. The data presented in this thesis help provide a better
understanding of the CD4 + T cell response durg virus infections as well as highlight
some important similarities and differences between the CD4+ and CD8+ T cell responses
during acute viral infections. I have made several novel observations in the course of these
studies including:
1. CZ- , a mAb generated in our laboratory, represents a novel activation and memory
marker for murine CD4+ T cells.
2. LCMV infection induces primarily a Thl virus-specific cytokine response.
3. There is a more profound CD4+ T cell response durng LCMV infection than has ever
been previously recognized.
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4. The LCMV-specific memory CD4+ Thp remams extremely stable into long-term
immunity. In addition, heterologous virus infections fail to significantly perturb this
stable CD4 + memory T cell pool, even under conditions that result in the reduction of
CD8+ memory T cells.
5. CD4+ T cells can contribute to heterologous T cell-mediated immunity though the
production of cytokines such as IFN-
6. CD4+ T cells become unesponsive following a high-dose LCMV infection.
The mechanisms that underlie some of these important observations remam to be
identified. However, this thesis provides a foundation for further studies examg the
role of CD4+ T cells during viral infections.
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